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The Relevance of Nicotine to the Study of 
Synaptic Transmission 
I 
Action ofNicotine on Transmission in Autonomic 
Ganglia:- 
In 1863 Traube (see Heubner 1947) showed 
that nicotine slowed the dog's heart even after 
the vagus nerve had been cut and further that, 
after this action of nicotine, electrical 
stimulation of the vagus did not slow the heart. 
Schmiedeberg (1870) showed that atropine 
prevented the initial slowing effect of nicotine, 
and that, if atropine had not been given, 
muscarine would still slow the heart during the 
phase when electrical stimulation of the vagus 
was ineffective. Schmiedeberg and Traube 
concluded that nicotine stimulated and then 
blocked some connecting link between the vagus 
trunk and the site of action of atropine. 
In / 
2 
In 1889 Langley and Dickinson showed that 
the site of action of nicotine was the autonomic 
ganglia. They applied a 1¡% solution of nicotine 
to the superior cervical ganglia of the cat and 
produced pupilary dilatation, the same response 
obtained by electrical stimulation of the 
cervical sympathetic chain. Nicotine applied 
to the nerve trunks on either side of the 
ganglia did not produce this effect. After the 
stimulatory effects of nicotine had passed he 
noted that electrical stimulation of the 
sympathetic nerve trunk no longer produced 
pupilary dilatation although electrical 
stimulation of the postganglionic trunk did. 
Langley concluded from these observations 
that nicotine stimulated and then blocked the 
ganglionic elements in the sympathetic outflow. 
Using nicotine as a pharmacological tool 
Langley 1889 et seq. mapped out the sites of 
autonomic ganglia in the cat. If nicotine 
caused a stimulation followed by a block at a 
ganglion this was taken as evidence of the 
presence of a synapse. If nicotine was 
without effect it was concluded that the 
fibres / 
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fibres did not synapse at this point. The action 
of nicotine at ganglia, therefore, is extramely 
important because it was this action which was 
used to reveal the existence of ganglia. 
Langley (1901) showed that nicotine still 
stimulated the sympathetic ganglia after the 
preganglionic nerve had been cut and allowed to 
degenerate. He deduced from this that the site 
of the paralysing action of nicotine on the 
ganglia was the cell surface and not the nerve 
endings. 
The observation that such drugs as nicotine 
and esters of choline could mimic the effects 
of nerve stimulation eventually led to the 
consideration of the possibility that transmission= 
in the ganglion might proceed through a 
physiological chemical transmitting substance. 
This idea had already been proposed for 
transmission from the parasympathetic post - 
ganglionic nerve fibre. (Hunt and Taveau 1906, 
Dixon 1907). 
Dale (1914) showed that there were 
differences between the action of drugs on the 
ganglia and the postganglionic parasympathetic 
site. The alkaloid muscarine was active on the 
postganglionic parasympathetic site and inactive 
at / 
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at the ganglia whereas the reverse was true for 
nicotine. Acetylcholine which acts at both of 
these sites was in fact shown to be the 
transmitter at the end of the postganglionic 
parasympathetic nerve fibres. (Loewi 1921, Dale 
and Dudley 1929, Dale and Gaddum 1930, Dale 1933). 
Kibjakow (1933) described experiments in 
which he had artificially perfused the superior 
cervical ganglion of the cat and found that, 
when the preganglionic nerve was stimulated 
something appeared in the venous fluid which 
acted as a stimulus to the ganglion cells on 
reinjection, as shown by contraction of the 
nictitating membrane. This was the first real 
evidence that a chemical substance was 
responsible for transmission across tine synapse 
of a ganglion. Chang and Gaddum (1933) from 
their own obseuvations of the presence of an 
acetylcholine -like substance in extracts of 
sympathetic ganglia suggested that this substance 
might be acetylcholine. 
Feldberg and Minz 1933 showed that when the 
splanchnic nerve supply to the adrenal medulla 
was stimulated acetylcholine could be detected 
in / 
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in the venous blood if eserine was present to 
prevent its destruction. Feldberg and Gaddum 
(1933) using Kibjakow's technique added eserine 
to the Locke's solution perfusing the ganglia 
and showed beyond doubt that the active substance 
appearing in the venous fluid during 
preganglionic nerve stimulation was acetylcholine. 
The transmitter in autonornicgan îia 
therefore has been shown to be acetylcholine 
whose actions at this site are imitated by 
nicotine (Dale 19110. Feldberg and Vartiainen 
(1935) showed that there was a considerable 
similarity in the stimulant activity of these 
two compounds on the ganglia. They used the 
perfused superior cervical ganglion of the cat 
as described by Feldberg and Gaddum (1934) and 
added nicotine to the perfusion fluid. They 
found that the threshold for the stimulant action 
of nicotine was 100 ng. and for acetylcholine 
was 1 to 3pg. in the absence of eserine. 
The threshold dose for acetylcholine when it was 
protected by 10 -6 w/v eserine was 50 to 200 ng. 
which is quantitatively similar to the threshold 
for nicotine. 
Feldberg and Vartiainen (1935) further 
showed,/ 
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showed, in agreement with Langley(1901), that the 
site of the blocking action of nicotine was at 
the cell surface and not the nerve endings for 
they showed that the release of acetylcholine 
from the nerve endings was unimpaired during 
nicotine block. 
The blocking action of nicotine on the 
ganglia has been further studied by relatively 
few workers. Koppanyi, Dille, and Linegar 
(1936) gave physostigmine (0.2 -0.35 mg. /Kg. i.v. 
femoral) to animals which had been given 
sufficient nicotine (2 -10 mg. nicotine salicylate/ 
Kg. i.v.) to block the superior cervical ganglion, 
and claimed that this abolished the nicotine 
block, as shown by the return of the normal 
response to preganglionic nerve stimulation 
(i.e. dilatation of the pupil, exophthalamous 
withdrawal of the nictitating membrane, widening 
of the palpebral fissure and occasional rises 
in blood pressure). They supposed that nicotine 
(and curare) caused a ganglion block by 
interfering with the production of acetylcholine 
by the nerve endings. The evidence, however, 
is that nicotine does not prevent the release 




The reversal of nicotine block by eserine 
could be explained if nicotine were acting as a 
competitive blocking agent, but there is no 
evidence (see below) that this is so. In these 
circumstances the reversal of the block of 
nicotine by eserine requires further study 
particularly as the results of Koppanyi et al 
were based on experiments on only a small number 
of animals, (3 dogs, Li. cats, and 3 rabbits) and 
their experimental technique makes it difficult 
to tell how much eserine reached the ganglia. 
It is also difficult to tell whether the eserine 
was given during a complete block or during an 
early recovery phase from nicotine block,a factor 
which may be important in deciding whether this 
second phase of block is truly competitive or is 
due to a desensitisation of the "receptors" to 
transmitter. 
A physiological study of the mode of 
nicotine block at the ganglia was made by Paton 
and Perry in 1953, They stimulated the cut 
preganglionic sympathetic cervical nerve of a 
cat at varying frequencies and recorded the 
action potentials produced in the postganglionic 
nerve by means of external nonpolarisable 
electrodes (one lead looped round the body of 
the ganglia and the other placed at the point 
where / 
where the postganglionicsnerve trunk had been 
tied and cut). Drugs were given in 0.2 ml. 
retrogradely intra- arterially or intra- venously. 
They found that large doses of nicotine, 
acetylcholine, and tetramethyl ammonium all 
produced a depolarisation of the ganglion 
accompanied with a reduction of the spike height 
of the action potentials. They noted, however, 
that'the depolarisation caused by nicotine was 
much more transient than that caused by the 
other two drugs and that the spike potential, in 
one experiment with 300 jig. nicotine i.a. did not 
reappear for 10 minutes, nor return to normal for 
30 minutes after depolarisation had passed off. 
In a similar experiment with tetramethyl ammonium 
the recovery from depolarisation was much slower 
and almost paralleled the recovery of the spike 
height to normal. 
These observations suggested to them that 
nicotine may have a mixed action: partly 
acetylcholine -like and partly by antagonising 
the effects of acetylcholine. 
To test this hypothesis they gave a dose of 
200vg. of nicotine i.a. and repeated tr_is 4 
minutes later when the depolarisation caused by 
the first dose had almost passed off and they 
found that only an eighth of the original 
depolarisation was produced. A third dose of 
200,.ag. nicotine given 9 minutes later when the 
spike potential had returned to 50; of normal 
produced / 
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produced 50% of the original depolarisation. 
The presence of a block without depolarisation 
in which there is resistance to further 
depolarisation by nicotine suggested to them a 
competitive type of block. 
That this is a form of competition in the 
sense that the continued presence of the first 
dose at the sites of action ( "receptors17) 
prevents the second dose from producing its 
action (depolarisation) can neither be readily 
accepted nor disproved from the evidence given. 
A test showing that this was a truly reversible 
form of competition (cf. atropine and acetyl- 
choline at muscarinic site) would have been to 
show that there was a quantitative increase in 
the extent of the depolarisation produced (at 
the same stage of the second phase of nicotine 
block) by successively doubling the second dose 
of nicotine given. Without such a test being 
performed one may equally well conclude from the 
evidence given -that the second phase of block by 
nicotine was due to a "desensitisation" of the 
receptors of the ganglion surface to 
depolarising drugs (cf. the evidence given below 
for the neuro- muscular junction). During this 
phase the receptors would be refractory to 
further / 
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further doses of nicotine and it would be only 
on recovery to their "sensitive" state that 
further depolarisation would occur. In such a 
block it can be seen that the percentage of 
"sensitive" receptors at any given stage in 
recovery would be the factor which determined 
the degree of depolarisation produced by further 
doses of nicotine. If this was the case only 
one degree of depolarisation could be produced 
no matter how large a dose of nicotine was 
applied at any one stage during recovery. 
From the results given by Paton and Perry it 
can be seen that maximum depression of the spike 
potential (and presumably ganglion blockade) 
occurred within the time required for the 
depolarisation produced to reach a maximum. 
This is of importance in this work as it is the 
initial degree of block (during depolarisation) 
which is taken as an index of nicotine- blocking 
activity and not the duration of block which 
would presumably be more dependent upon the 
extent of phase II block. Large doses of 
acetylcholine (1 mg. i-.v.) and tetramethyl 
ammonium (300pg, ia.) showed a similar 
relationship in time between the onset of 




The relationship, if any, between the 
depolarisation produced and the degree of block 
present is not a simple one in the case of 
nicotine. This is also true, however, for the 
block caused by large doses of acetylcholine. 
Paton and Perry studied the time courses of the 
development of, and the recovery from, both 
depolarisation and block. They found that the 
reduction of the spike height was greater for a 
given degree of depolarisation the longer the 
depolarisation had been present. 
Thus, although acetylcholine differs from 
nicotine in that depolarisation appears to remain 
for the duration of block there is an appreciable 
return to the nondepolarised state whilst the 
block continues with a much slower rate of 
recovery, (e.g. from Figure 4 the depolarisation 
expressed as a percentage of the initial spike 
height recovered from about 170% to 50% whereas 
the block expressed as the percentage reduction 
of the spike height had only recovered from 
75% to 606 in a similar time) . From these 
observations acetylcholine appears to hold an 
intermediate position between nicotine and 
tetramethyl ammonium. There may thus be a 
greater resemblance between the blocking action 
of / 
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of nicotine and acetylcholine than is at first 
sight apparent. 
Eccles (1956) studied the action of nicotine 
on the isolated superior cervical ganglion of the 
rabbit. She used low concentrations which 
produced a sustained depolarisation of the 
ganglion and studied the change this produced in 
the spike and the after potentials to 
preganglionic nerve stimulation. The 
characteristic effect was a depression of the 
negative (N) wave and an increase in the after 
positivity (F wave). The meaning of these 
effects is still obscure althouS_i it has been 
suggested that the P wave may be due to a 
prolonged high potassium conductance of the 
cell membrane (cf. Hodgkin and Huxley 1952). 
This P wave also follows after the motoneurones 
have been depolarised by extrinsic currents, 
i.e. externally applied currents from electrodes 
on the cell surface (Coombs, Eccles and Fatt, 
1955). Larger doses of nicotine were found to 
suppress both the spike and after potentials. 
These results on the rabbit ganglion are in 
agreement with those obtained on the application 
of nicotine to the cat's superior cervical 
ganglion / 
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ganglion, (Eccles 1955 a and b), but as stated 
above the meaning of the externally recorded 
after potentials is still unknown and thus no 
valuable conclusions on the action of nicotine 
may be drawn from this work. Evidence is 
required on the action of nicotine on the 
potentials recorded with intracellular electrodes. 
To conclude, the study of the action of 
nicotine on the ganglion has been of great 
importance historically, and the resemblance of 
its effects to those of the physiological 
transmitter acetylcholine leave little doubt 
that an understanding of the action of the one 
will be useful in the understanding of the other. 
1L. 
zz 
The Action of Nicotine on Transmission at the 
Neuromuscular Junction:- 
At the neuromuscular junction nicotine has 
a twofold action. There is an initial 
stimulation which may be either contraction or 
contracture (see below) followed by a block of 
transmission. 
Chemical Transmission at Neuromuscular Junction. 
The chemical transmitter at the 
neuromuscular junction, like that at the ganglion, 
has been shown to be acetylcholine. Hess (1923) 
perfused the voluntary muscles of frogs and 
that, when he stimulated the nerve supply, 
an acetylcholine -like substance appeared in the 
perfusate. Dale (1930 removed the superior 
cervical ganglia of a cat and allowed the 
autonomic nerves to the tongue to degenerate. 
He perfused the tongue with Locke's solution 
containing eserine and found that when the motor 
nerves were stimulated acetylcholine appeared in 
the perfusate. Dale, Feldberg and Vogt (1936) 
cut the motor nerves supplying various skeletal 
muscles of the cat and found that denervated 
muscles did not release acetylcholine 
into the 
perfusion fluid when the muscle was 
stimulated 




showed that the acetylcholine found in the 
perfusate after nerve stimulation was released 
from the nerve endings and gave added support 
to the now accepted theory that transmission 
across the synapse at the neuromuscular junction 
is mediated by the chemical transmitter, 
acetylcholine. 
Stimulant Action of Nicotine. 
(a) Contracture. The effects of 
acetylcholine and nicotine on striated 
(voluntary) muscle are complex and 
extremely variable. On certain 
muscles of the frog, tortoli.,se, and 
bird, acetylcholine and nicotine 
produce a slow long -lasting contraction 
of low tension: this has been called 
a contracture to distinguish it from 
the rapid twitch contraction normally 
Produced in voluntary muscle by motor 
nerve stimulation. Riesser and 
Neuschlosz (1921) showed that 
contracture was produced by 
acetylcholine in low concentrations 
(lO -5 w/v for frog rectus). 
Sommerkamp (1928) and iachholder and 
Ledebur / 
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Ledebur (1930) showed that in the frog 
and tortoise the muscles which produced 
contracture in response to the 
application of acetylcholine were 
those considered to be most important 
for the maintenance of normal posture. 
(b) Contraction. Contracture is not the 
only form of stimulant response shown 
by skeletal muscle in response to 
nicotine -like drugs. Nicotine and 
acetylcholine when injected rapidly 
into certain voluntary muscles produce 
an initial Quick contraction. For 
instance Langley (1907) showed that 
on the frog sartorius nicotine 
(10 -2 to 10 -3 w /v) produced twitches 
and a quick type of contraction, 
resembling a short tetanus, prior to 
the slowly developing contracture. 
Feldberg and finz (1931) and Brown 
Dale and Feldberg (1936) also 
observed quick contractions of normal 
mammalian muscles when moderate doses 
of acetylcholine were injected close 
arterially.:' 
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arterially. (20íg. into the 
gastrocnemius muscle of a spinal cat). 
Presence of Two Types of Fibres. 
(1) Frog. These results suggest that 
there are two types of muscle fibres: 
one which responds with a rapid twitch, 
and the other which developes a slow 
contracture on the application of 
nicotine -like drugs. Katz and 
Kuffler (1941) and Kuffler and Vaughan 
Williams (1953 b) obtained evidence 
that this was so: they demonstrated 
the presence, in frog muscle, of 
which differ 
the "fast" twitch fibres in that they 
have a lower membrane potential, and 
they never give propagated muscle 
action potentials on nerve stimulation. 
(2) Chicks. Chicks have been used for 
some time (Buttle and Zaimis 1949, 
Child and Zaimis 1954) to distinguish 
between two types of neuromuscular 
blocking agents. One type, of which 
decamethonium is typical (see below) 
produces a contracture of certain 
muscles, especially those in the neck. 
Isolated / 
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Isolated preparations of the 
semispinialis (Child and Zaimis 1954) 
and the biventer cervicis (Ginsborg and 
Warriner 1960) have been used for 
qualitative and even quantitative 
investigations of neuromuscular 
blocking ag,ents. 3ins.borg (1959 and 
1960) has shown that the biventer 
cervicis contains two types of 
fibre, one of which responds to 
acetylcholine and to depolar'i:sing drugs 
like deva Lethonium by producirg a 
contracture whereas the other eiP gi veá, 
a contraction in restonse to nerve 
stimulation and is blocked by 
neuromuscular blocking agents of 
either type. 
Sz1n.sLo ?'g (1r= kAAs deduced from 
a study of the spontaneous activity 
recorded from mus'c_e fibres in the 
chick that the, type which prodiuces 
contracture is sáwp'_'l? ed a number of 
axons and has neuromuscular junctions 
distributed at many joints along it, 
whereas the twitch fibres are 
sup-plied/ 
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supplied by a single axon with a focal 
end- plate. The "slow" fibres of the 
amphibian muscles have also been shown 
to have a diffuse form of innervation 
Kuffler and Vaughan Williams 1953a, 
Burke and Ginsborg 1956, Burke 1957). 
One difference between the "slow ?" 
amphibian muscle fibres and the 
corresponding "contracture" fibres in 
chick is that the latter can give a 
propagated action potential on nerve 
stimulation ( Ginsborg 1959). 
Connection between Depolarisation and Contracture: 
Ginsborg (1960) has pointed out that the 
distance between adjacent junctions in the 
diffusely innervated fibres of the chick is, at 
the most, of the same order of magnitude as the 
space constant of the fibre. Thus, 
pharmacological agents Mich cause depolarisatior 
at the neuromuscular junction may be expected to 
produce a relatively unifoine depolarisation of 
the surface of such a muscle fibre. Ginsborg 
concludes that if contracture is intimately 
related to depolarisation it seems likely that 




the contracture of such avian muscles. 
In their physiological behaviour these slow 
fibres are clearly quite different from those 
which produce a twitch response. 
Pharmacolo Tical difference between Fibres 
A pharmacological difference between the 
two types of muscle fibre is revealed by the 
action of antagonists. Raventos (1937) found 
that atropine abolished the contracture but had 
no effect on the twitch whereas curarine (a 
mixture of the alkaloids from tube curare) 
decreased or abolished the twitch but had no 
effect on contracture. 
Quantitative Comparison of the Neuromuscular 
Junction and the Ganglion : - 
The stimulant activity of nicotine on 
normal voluntary muscle is a hundredth of that 
of acetylcholine, for Bacq and Brown (1937) 
showed that an injection of 5004g. into the 
artery supplying the gastrocnemius or the 
tibialis anticus of the cat caused a rapid 
contraction equivalent to that caused by 5µg. 
acetylcholine. 
at the ganglion 
as effective as 
ganglion cells. 
This differs from the situation 
where nicotine is approximately 
acetylcholine as a stimulant of 




In higher concentrations the stimulant 
action of nicotine is normally followed by a 
block of transmission. Langley (1907) showed 
that nicotine causes a block at the neuro- 
muscular junction in doses which left both the 
nerve and muscle fibres functionally responsive. 
This implies that the drug blocks by an action at 
the end -plate region. .2111 drugs like nicotine 
which cause contraction of striated muscle also 
have this paralysing action if they are allowed 
to remain in contact w i th the muscle fibres. 
Bacq and Brown (1937) observed that on the cat 
gastrocnemius and tibialis muscles the paralysis 
produced by nicotine could be reversed completely 
by a tetanus or by the application of the sale 
concentration of acetylcholine which normally 
caused a twitch. 
The effects of DeeaE.e tnon i um on t_., end-plate 
The nature of the block caused by drugs at 
the neuromuscular junction has been studied to 
greater extent than on the ganglion, and it has 
been shown that not all drugs cause a .n initial 
stimulation before block ensues. (Paton and 
Zaimis 19L9, 1950 and 1952). Marrs and Paton 
(1951) / 
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(1951) showed that the block caused by 
( +)- tub ocurarine differed from that caused by 
decamethonium in that(+)- tubocurarine did not 
cause a depolarisation of the end -plate region of 
the gracilis muscle fibres of the cat whereas 
decamethonium caused a longlasting depolarisation 
Burns and Paton observed the following effects 
of decamethonium on the gracilis muscle: .(i) it 
produced a depolarisation of similar duration 
as the block (Paton and Zaimis 1949); (ii) the 
end -plate during block did not respond to direct 
electrical stimulation; (iii) the conduction of 
a muscle action potential along the fibre was 
stopped at the end -plate region during block; 
(iv) the propagation theshold of the end -plate 
was raised; (v) artificial repolarisation of 
the end -plate region reversed the block. 
The effect of ( +) Tubocurarine on the end -plate 
Earlier work by Eccles, Katz, and Kuffler 
(1941) and others showed that the block caused 
by "curare" at the neuromuscular junction was 
due to an increase in the threshold of the 
end -plate to acetylcholine with no concomitant 
depolarisation. Burns an Paton (1951) showed 
that in the gracilis muscle of the cat this 
block / 
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block differed from that caused by decamethonium 
in that conduction of the muscle action 
potentials was not stopped at the end -plate region 
and that the threshold for the propagation of the 
spike action potential from the end -plate 
potential was only1/3.5 times the threshold for 
decamethonium. 
Classification into two types of block 
Burns and Paton concluded that whereas 
( +) - tubocurarine blocked by increasing the 
threshold of the end -plate to acetylcholine, 
decamethonium blocked by producing a persistent 
depolarisation of the end -plate region. 
In support of the idea it was noted that 
the block caused by one of these types of drugs 
could be reversed by the application of one of 
the other type. For instance Hunter and Pascoe 1 
(1951) found that moderate doses of 
decamethonium antagonised the effects of 
( +) - tubocurarine on the tibialis anterior and 
the gracilis muscles of the cat. Larger doses 
caused an increased block. Burns and Paton 
(1951) showed that (+) - tubocurarine 
applied 
to a muscle which was blocked with 






however, returned when the end -plate potential 
had been r educed by a third. 
An attractive feature about this simple 
classification of drugs into "curare -like" and 
" decamethonium- like" is that the action of 
eserine on the two types of block can be 
explained. For instance, Paton and Zaimis 1949 
noted that on the cat tibialis eserine reversed 
the block caused by ( +) - tubocurarine 
(presumably because the increased concentration 
of acetylcholine competitively displaced the 
( +) - tubocurarine from the sites of action, 
"receptors ") whereas eserine did not reverse 
but sometimes even increased the block due to 
decamethonium (presumably because the increased 
concentration of acetylcholine caused further 
depolarisation and thus increased the block). 
Further support for the hypothesis was the 
observation that the sensitivity of different 
muscles to decamethonium not only varied from 
species to species (Paton and Zaimis 1952) but 
depended upon the type of muscle. There 
appeared to be a reciprocal relationship 
between / 
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between the sensitivity of a given muscle to the 
two types of blocking drug. For instance 
Paton and Zaimis 1951, and Zaimis (1953) showed 
that the stimulant action of decamethonium on the 
normal soleus (a "red" muscle) was more 
persistent than on the normal tibialis (a "white" 
muscle) whereas ( +) - tubocurarine was more 
effective in blocking "white" muscle than it was 
"red" muscle. 
The two Phases of block produced by 
Decamethoniun. 
The action of decamethonium, however, 
cannot be regarded in all species as one of pure 
depolarisation. Jenden, Kamijo, and Taylor 
(1951) observed that decamethonium had a 
"biphasic" blocking action on the isolated 
rabbit lumbrical muscle. The first phase of 
block had the properties of decamethonium in 
vivo and the second phase with a slower rate of 
onset progressed to a steady level. They found 
that this second phase of block could be 
reversed by increasing the potassium 
concentration, and by adding eserine. Zaimis 
(1953) studied the action of decamethonium 
and succinylcholine on eight different species 
and / 
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and found that on certain muscles (e.g. the 
tibialis and soleus of the monkey, rabbit and 
hare) these drugs initially produced a type of 
block which had the characteristics of a 
depolarisation block which was followed by a 
second phase of block which had the character- 
istics of competitive block. (A tetanus was 
not sustained and the block was antagonised by 
neostigmine) . 
The observation by Burns and Paton (1951) 
that successive doses of decamethonium produced 
a progressively smaller depolarisation in the 
gracilis muscle of the cat is compatible with the 
idea of a dual mode of action even on this 
muscle. 
These tests, however, are not conclusive. 
The justification for the use of the action of 
anticholinesterase in reversing block as a test 
for the presence of a ( +) - tubocurarine -like 
competitive block is discussed below. The 
reversal by K +ions of the second phase of block 
must not be taken as evidence for the presence of 
a ( +) - tubocurarine -like block as it is known 
that potassium has a direct effect on the muscle 
fibre / 
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fibre as well as the end- plate. 
More evidence about the nature of the 
second phase of block caused by decamethonium 
was obtained when the theory of depolarisation 
block was tested as a cellular level using 
microphysiological techniques. 
ì\Iicronhysíolo ical Study oÌ Phase II 
Thesleff (1955) using the sartorius nerve - 
muscle preparation from frog with internal and 
external recording found that acetylcholine, 
nicotine, decamethonium and suxamethonium all 
a c ted in á qualitatively similar way. During 
the first few minutes there was a block 
accompanied by a brief depolarisation. which 
subsided spontaneously without the removal of 
the block. He found that maximal neuromuscular 
blockade did not occur during this depolarisation 
phase but only occurred when the :membrane 
potential had returned to about normal. During 
this block of transmission the end -plate regions 
of the muscle were insensitive to the 
depolarising effect of acetylcholine. Thesleff 
concluded that the neuromuscular block caused by 
these depolarising drugs was not due to a 
persistent depolarisation of the end -plate or 
adjacent / 
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adjacent muscle membrane but to a debrea e in -?,e 
sensitivity of the end-plate to the transmitter 
substance. These observations ?la7f; en 
repeated on frog muscle by del Castillo and Zatz 
(1957) and have been e-:.:ehded, to .:.a.malian 
muscle by Axelsson 
Thesleff (1958). 
and hesieff ( 17;53 
In all :h 
and 
it 
has been found that with deca7Peonitm, and 
decamethonium-like drugs (acet;;:bh:lie, 
carbachol, nicotihe, etc.) the end-te 
rebolarised the 
and that after this blbc 
dur-1.7 v;hich were 
desensitised tb 
acet:lcholine 9 - ih 
This 
a7L az 
at, the za-r: 
bbservbh of '_Lez,:naitizstion to 
ylcholine when the secomd, ghat;e of 
--:b.,.:thonium block was stmiled at the cellular 
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level is clearly at variance with the results 
obtained from the response of the whole muscle 
studied macropharmacologically. If the end- 
plate region is completely desensitised how is it 
that eserine can reverse the block? This is 
where the main difference between the two 
techniques becomes apparent: when micro - 
physiological recordings are made from one fibre 
the indicatión of complete block is the failure 
to record an action potential on the application 
of acetylcholine, whereas in the whole tissue 
preparation the indication of block is the 
failure to produce a contraction on nerve 
stimulation. This block of contraction, however, 
does not necessarily mean that all the receptors 
or indeed all the end- plates are blocked. It 
may be that there are sufficient unblocked 
receptors present to produce a contraction due 
to the lowerin of their threshold to nerve 
stimulation by the presence of the increased 
acetylcholine. This argument is strengthened by 
the fact that in many published records 
purporting to show the reversal by eserine of this 
second phase of block, the degree of block was 
less than 100%. In such circumstances there must: 
be / 
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be receptors which are not occupied by the 
blocking drug. 
Another explanation of this reversal caused 
by eserine is that it is due to a repetitive 
firing of the receptors which have recovered 
from their desensitised state. The number of 
such receptors may be large in whole animal 
experiments, where the effective drug 
concentration is being reduced steadily, or in 
isolated preparations after the drug has been 
washed out. 
KINETIC THEORY 
(a) Intermediate complex 
Del Castillo and Katz (1957) have tried to 
,explain the various interactions of drugs at the 
end- plates by the application of kinetic theory. 
They suggest that the drug receptor reaction which 
produces depolarisation is a two -step process 
(by analogy with the cholinesterase - 
acetylcholine reaction - Augustinsson 1948 and 
1949). 
This reaction may be represented: - 
S + R r-= S .R. r--= S .R' 
where S is the substrate, R the hypothetical 
receptor, S.R.'an intermediate inactive complex, 
and / 
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and S.R.'the depolarising complex. 
This intermediate complex may be used to 
explain the blocking action of both ( +) - 
tubocurarine and decamethonium (during the first 
phase of block) . ( +) - tubocurarine for 
instance may be considered to form a reversible 
intermediate complex (S.R) without proceeding 
to the next step. Del Castillo and Katz (1957) 
showed that the rate of development of 
depolarisation with decamethonium and other 
depolarising drugs was much slower than that of 
acetylcholine. This slow passage through the 
intermediate step may be the reason for the 
antagonism of decamethonium to the depolarisation 
caused by fast and powerful agents like 
acetylcholine and carbachol. 
(b) Connection between depolarisation and 
desensitisation:- 
Katz and Thesleff (1957) have considered 
two main hypothesis to explain the relationship 
between depolarisation and block: either that 
the desensitisation phase is unrelated to the 
depolarisation phase and in fact develops in 
parallel, or the desensitisation occurs only 

















































































































































































































































































































































































































































































































































































































































































































































































































An interesting hypothesis they have put 
forward to satisfy this requirement may be 
represented : - 
S + A N 
( fast) 
( slow) k2 k4 k3 kl ( slow) - (3) 




where a and b are affinity constants, kl, k2, k3, 
and k4 are the rate constants. 
k 
1 k2 
Equilibration requires b / 
a 
k3 k4 
This scheme would fit if kl» k3, b» a 
and b/a > kl /k2. A feature of this hypothesis 
is that the free receptors are distributed, even 
in the absence of the drug, between the states A 
and B: that is a number of the receptors will be 
in the refractory form and on account of their 
very high affinity (b /a » 1) they will 





This may explain their observation that a 
small steady dose of a drug may facillitate 
beyond normal the depolarisation caused by an 
added pulse of the drug. If there are available 
large numbers of B type receptors, of high 
affinity for the drug, but with no depolarising 
power, then the effect of a small dose would be 
mainly to occupy and partially to saturate these 
sites. If a second dose is added a smaller 
fraction of the drug molecules would be absorbed 
by sites B and thus a larger fraction would 
become available for depolarisation than if the 
same total dose had been given at once. A 
different form of facil itation is discussed 
below under the heading of drugs which have 
significant activity on the cholinesterase. 
Thus, although the available results are not 
yet accurate enough (quantitatively) to provide 
a secure basis for kinetic theory they do allow 
the rejection of certain hypothesis such as (1) 
and (2). It is not yet possible to decide 
whether the depolarisation and desensitisation 
are consecutive or parallel phenomena but one 
of/ 
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of the more attractive hypothesis (3) includes 
both of these possibilities and also gives an 
explanation of one of the forms of facilitation 
observed. 
Anticholinesterase Activity as a Complicatin 
Factor:- 
The modes of neuromuscular blocking action 
described above, however, may be complicated by 
the ability of the drug to inhibit cholinesterase. 
Many neuromuscular blocking drugs have this 
property and this affects greatly their apparent 
behaviour as neuromuscular blockers. For 
instance the drug Mytolon (Win 27147) is a 
powerful inhibitor of cholinesterase: 
*Table of p150 Bovine iced Cells Plasma 
6.8 4.5 b ytolon 
Eserine 6.6 6.7 
Tensilon 5.3 5.6 
Neostigmine 6.9 
(substrate final concentration 6.7 1. 10ví) 
Because it was not reversed by Tensilon it 
was originally classed as a "depolarising 
blocking agent ". If, however, the effect of 
Tensilon in reversing the blocking action of 
curare -like drugs is due to its anti - 
cholinesterase activity (e.g. Iobbiger 
1952, 
Smith / 
* From Tabachnick, et al. (1958) 
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Smith et al 1952 and Katz and Thesleff 1957) it 
is not surprising that it will not reverse the 
block caused by a drug like Mytolon which is a 
more potent anticholinesterase than itself. The 
compounds ambenonium (Pu ytelase in 8077) and 
Win 8078 (Karczmar 1957, Blaber 1960) are other 
examples of drugs which have both anti- 
cholinesterase activity and blocking activity. 
The reversal by the latter compound of both the 
.block caused by ( +) - tubocurarine and that 
caused by decamethon.ium may be due to its 
anticholinesterase activity and to its "curare - 
like" activity respectively. 
It is t.us important, when studying the 
mode of neuromuscular blocking action of a new 
compound, to find out, by means of invitro 
experiments, whether it has any significant 
inhibitory activity on cholinesterase. 
Mode of Block by nicotine 
To conclude the mass of evidence suggests 
that on the rat diaphragm- phrenic nerve 
preparation nicotine like other depolarising 
drugs blocks by a dual mode of action. It 
appears / 
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appears ( Thesleff 1958) that on this preparation 
the rate and duration of the initial depolarisa- 
tion phase are such that the subsequent receptor 
desensitisation is entirely responsible for the 
block although the degree and rate of onset of 
this desensitisation may be graded according to 
drug concentration used. For instance the 
duration of the depolarisation due to nicotine in 
frog muscle is similar to that due to 
acetylcholine, i.e. 5 minutes (Thesleff 1955) 
and this may be even less in mammalian tissues 
where reactions are generally faster (Thesleff 
1958). The predominant phase of block may 
however depend on the particular muscle used. 
The fact that Burns and Paton (1951) have 
reported that in the gracilis muscle of the cat 
an anodal current may even at later stages 
relieve the neuromuscular block produced by 
decamethonium suggests that on this muscle 
desensitisation may develop only slowly and that 
consequently the duration of the depolarisation 
period may be prolonged. 
The main evidence that the second phase of 
block is a desensitisation of the receptors, 
rather / 
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rather than a "curare -like" reversible or of 
competition is drawn from the use of 
microphysiological technioues. It may be 
concluded that the use of pharmacological tests 
(e.g. reversal by eserine, acetylcholine, or 
tetanus) claimed to show that the second phase 
of block is "curare- like" are open to certain 
criticisms when they are applied to the 
classical phar:.acolo i cal whole muscle 
preparations in vitro (Taylor 1951) and in vivo 
(Bacq and Brown 1937) , especially when the height 
of contraction in response to nerve stimulation 
is taken as the index of blocking activity. 
The observed "reversal" may be an action either 
on the percentage of receptors which have not 
been blocked (desensitised) by the drug or or 
the percentage of the receptors which have 
recovered to their sensitive state either after 
washing out the drug from the bath in vitro or 
by removal or dilution in in v i vo experiments. 
Conclusion 
Thus on the neuromuscular junction the 
action of nicotine is qualitatively similar to 
that of the physiological transmitter 
acetylcholine / 
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acetylcholine in that it produces: contraction 
(Page 15), contracture (Page 15), depolarisation 




































































































































































































































































































































































































































































































































































































































































































































































































































































































the hypothesis. The is evience, however, 
that the partial -oo:-_-:L7e _leed not be 
'sited at an oxygen atom. Por instance Wels and 
Taub (1951) studied a series of :cetoamyl- 
trimethylamroniu:a spits, on the heart of Venus 
Hercenaria, and still found the 4 keto compound 
to be active although the partial positive 
crge Z..1 a carbon atom. This compound was 
found to have the sa e activity as acetylcholine 
on the :ioz. 
This idea, that the partial oositive cIre 
need not be on an o4ygen atom, might account for 
the activity of nicotine itself. 
In the pyridine ring teot, erciI carLgam 
a partial positive charge. This is 
by the great ease of att-,--c_t by 
2--cleohilic reagents (e.;-. by sould0. Thc 
.istribution, calculated by imagcaelt, 
and C;oul on (1947) shows that relative 
to the 3 arbn atom, the 2 smelt !!!! (and 6) carton 
atoms cam' an sp)preciable positive Charge. 
When there is a w%,coti n th It-egeita 
the 4.artial. 2ceitive charge ma tale 2 ant 
carbois 
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carbon atoms is even greater:- 
+ .18 + . 29 
+ .05 + .08 




- .58 H 
- .93 
(Proni Albert 196C) 
In nicotine the pyridine ring is attached to 
the ß position of the pyrrolidine ring by a 
single bond from the 0 position. There is free 
rotation about this bond and consequently either 
the 2 or the 4 carbon atoms of the pyridine ring 
can easily assume the same position relative to 
the pyrrolidine nitrogen atom. 
Taylor (1951) calculated from the 
dissociation constants of nicotine that it was 
mainly present as the pyrrolidinium ion at body 
pH (i.e. with the proton on the pyrrolidine 
nitrogen). The pyrrolidine nitrogen can 
therefore be compared with the cationic head in 
acetylcholine and the partial positive charge on 
the 2 and La. position can be compared with the 
partial positive charge on the ether 
oxygen of 
choline phenyl ether. 
This 
143 
This idea rece].,ves sane E ;art fx tase 
fact tcat (11-) and (-) to be 
ecuiactive. They have not :-_-;en t ested on 
isolated tissue preparations A they nave been 
found to have identical tori city an the gAnea- 
D ig (Hicks and Sinclair 19147). Brtcke 
and Jett (1335), howeve.P, f ound na z,igITTI fleant 
dif_ between the acti (40 ant. 
___7,.osine on the blood 71r-;=ure, TeS21ra trians, 
7:Le heart of 
althouh ib T e were some sii;r4at difference 
fnog muscle and . nerve-mnscie oreparations. 
To test the hyuothesis and alzo to examine 
of nemovin: -e assymetric centre 









To examine the effect of ouaternisation of 
the substituent nitrogen compounds of the 






linked Ñ 1CH3 linked 





To examine the effect of successively 
replacing the methyl groups in the cationic head 





me thylp ip eridino 
were tested: - 4 CH; 
-C9&- N C143 
Crt1CH3 
4 ICHT 
CNrAI-C WIC W3 
cH:CN3 
To examine the effect of replacin__ the 
pyridine ring by a benzene ring the following two 





CHI^ CHI -NN.' 
CO3 
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These c,onrpounds were tested on:- 
1. Rat Phrenic nerve -diaphragm preparation 
(page 49) 
2. Chick biventer cervicis preparation 
(page 51) 
3. Cat superior cervical ganglion preparation 
(page 54) 




Relative Stimulant Activity of phenyltrimethylammonium 
Compounds on Denervated Tibial Anterior 
Muscle of Dog: 
on weight basis 
m, hydroxyphenyltrimethyl - 
ammonium bromide = 1.0 
(Recalculated from Randall and Lehmann 1950 
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Pharmacology of Related Compounds 
Some compounds resembling those listed above 
have been prepared and tested, but not 
specifically for nicotine -like activity. One 
group, consisting of phenolic quaternary salts, 
was studied primarily for their ability to 
reverse the action of ( +) - tubocurarine by 
Wescoe, Riker, and Brothers (1949), Randal and 
Lehman (1950) and Randall (1950). The tests 
did, however, include a comparison of the 
ability of the compounds to cause a contracture 
of the denervated anterior tibial muscle of the 
dog and the results are shown in Table 1 
(calculated from Randall 1950). 
Similar compounds have also been studied by 
Kuperman, Gill and Riker (1961) for their 
effects in potentiating the twitch response of 
the cat gastrocnemius muscle to nerve stimulation, 
and as inhibitors of cholinesterase. With one 
group of compounds (3 hydroxy -, and L hydroxy-, 
trialkylammoniurn salts) there was a correlation 
between these two activities; but with a second 
group there was no such correlation. The dose - 
effect (potentiation) curves of the second group 
were / 
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were much flatter than those of the first group. 
A third ;zroup of compounds only depressed 
conduction. This block may be a measure of the 
ability to produce desensitisation, a nicotine - 
like activity. Phenyltrimethyl ammonium was the 
drug with the highest blocking activity. It is 
possible that with the compounds of the inter- 
mediate group there exists the ability to 
produce both effects: anticholinesterase 
(potentiating) and nicotine -like (blocking) 
which may well act in opposition to varying 
extents. This was not the view of the authors 
who emphasise the possibility of an action at 
the presynaptic nerve terminal. 
Another related substance is Leptodactyline 
(Glgsser 1960, and Erspamer and Gl'ásser 1960) . 
This produced neuromuscular block being more than 
28 times as active as nicotine on the cat sciatic- 
gastrocnemius preparation. It also appeared to 
have considerable nicotine -like activity, being 
40 to 100 times as active as nicotine on the frog 
rectus, 8 times on the cat nictitating membrane 
preparation, 2 to 4 times on the blood pressure 
of a spinal cat and 1 to 2 times as active as 
nicotine on the leech. Some analogues of 
leptodactyline have been prepared by these 
workers but as yet no reference to their activity 




Although in the introduction, for 
historical reasons, the activity at the ganglion 
has been discussed before the activity at the 
neuromuscular junction, in this section the order 
is reversed. More work has been done with the 
compounds on the neuromuscular junction than on 
the ganglion because the two nerve- muscle 
preparations used (the rat phrenic nerve - 
diaphragm and the chick biventer cervicis - see 
below) are much easier to put up than the ganglion 
preparation used (cat superior cervical ganglion). 
Figure (i) 
Rat Phrenic Nerve -Diaphragm Preparation 
Doses added to 25 ml. bath 
No = 2.50 Nicotine 
N2 = 50 fl 
Di = 2501N- pyridyl methyl 
D2 = 50[1M((dimethylammonium 
(W = Wash 
WN2 W.D2 VV, D2 WN2 
RAT PHRENIC NERVE -DIAPHRAGM 
NEUROMUSCULAR BLOCKADE 
Krebs' Solution 37 °C. gassed 5% CO2 and 95% 02 
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Activit at the Neuromuscular Junction: - 
T The Rat Phrenic Nerve - Dia-.hra=m Pre ration 
Bulbring 1946 
Rats of either sex weighing between 150 and 
250 grams were used. They were killed by a blow 
on the head and were bled out. The thorax was 
opened up exposing the left half of the diaphragm 
and the phrenic nerve. An incision was made 
through the left abdominal muscles along the 
costal margin. A fan -shaped strip of diaphragm 
about 12mms. wide at the costal margin and about 
3Ilmi1s. wide at the tendinous end was cut out. The 
phrenic nerve was dissected out and was cut as 
high up as possible leaving about 2.5cros. attached 
to the muscle. The muscle and nerve during this 
dissection were kept moistened with Krebs' 
bicarbonate solution. 
The dissected muscle was placed in Krebs' 
solution in a Petri dish. A thread was tied 
round the end of the nerve and either a strong 
linen thread or a wire was tied round the 
tendinous end of the muscle. 
The preparation was mounted on a double 
hook pushed through the costal margin and was 
suspended in Krebs' bicarbonate solution in a 
25ml.bath at 37 °C. The solution was gassed with 




The nerve was threaded through a pair of 
platinum electrodes as described by Bülbring and 
the thread or wire from the muscle was attached 
to a se d- isometric torsion lever (Condon 1957) . 
The nerve was stimulated maximally with 
square wave shocks of 0.75m.secs. duration at a 
rate of 4 to b per minute. The contractions of 
the muscle were recorded on a smoked drum. 
Method:- 
Antagonist activity was measured by 
estimatin= the molar concentrations of each 
drug which produced comparable degrees of 
block. The degree of block was measured 
by the percentage reduction in the height 
of contraction of the muscle. 
The activity was expressed as an 
eouipotent molar ratio i.e. the number of 
molecules of the drug which produced the 
same block as one molecule of the reference 
standard, nicotine (hydrogen tartrate) . 
At least two dose levels of each drug 
were used in each experiment, and the graph 
of the 3ogarithr of the dose to the response 
was compared with that for nicotine. The 
Potency ratio was obtained raphi.cally by 
taking the antilog of the horizontal distance -r-T , 
between the nicotine and the drug lines. 
lf 
51 
If these did not appear to be parallel the 
value was measured when the block was 50%. 
Wherever possible a four -point assay was 
employed and the potency ratio and fiducial 
limits were calculated by the method for the 
assay of penicillin described in the British 
Pharmacopoeia 1953. The equipotent molar 
ratio is the reciprocal of the potency ratio. 
All the tertiary compounds were tested 
on at least two rats; but the oli ternary 
compounds were only tested on one rat. 
The drugs were all made up in isotonic 
saline and were added to the bath from a 
blow -out pipette. They were left in the 
bath for 5 to 10 minutes depending on the 
rate of development of block, and were 
washed out by emptying and filling th bath 
three times with fresh Krebs' solution. 
The preparation was allowed to recover until 
the original height of contraction was 
restored before the next dose was given. 
II The Chicken Biventer Cervicis Preparation 
(Ginsborg & Warriner 1910) 
Chickens (500 -200 gms. Rhode Island Reds) 
were anaesthetised with ether. The back 
of the neck was plucked and the skin incised 
along the midline from the base of the 
neck to the skull, exposing the two biventer 
cervicis muscles on either side of the 
midline / 
Figure (2) 
Chick Biventer Cervicis Preparation 
Doses added to 15 ml. bath 
Ni = 40nM Nicotine 
N2 = 50nM + 
P1 = 2gM ß-pyridyl methyl piperidine 
P2 = 2.5 µM " 
n it 
CHICK BIVENTER CERVICIS 
CONTRACTURE 
Krebs' Solution 37 °C. gassed 5% CO2 and 95% 02 
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midline and immediately below the skin. 
A thread was tied round the upper belly of 
one of the muscles which was cut free from its 
attachment to the skull. The tendon and the 
muscle were dissected free and were removed with 
the lower tendon which attaches the muscle to the 
supraspinous ligament. 
A loop of thread was tied round the lower 
tendon so that the muscle could be hooked to the 
end of a rod which acted as a gas inlet. The 
upper thread was passed through the sane 
electrode as was used in the rat diaphragm 
preparation, and was attached to a light semi- 
isometric lever. The preparation was placed in 
a 15 ml. bath containing Krebs' solution at 37 °C. 
gassed with 5% carbon dioxide and 95jó oxygen. 
The electrode was lowered until it was in 
contact with the tendon surrounding the nerve. 
The nerve was stimulated maximally with square 
wave shocks of 0.75 m.secs. duration at a rate of 
L. to 6 per minute. The contractions of the 
muscle were recorded on a smoked drum. 
Method: - 
Agonist activity (i.e. the ability to 
produce / 
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produce contracture) was measured by 
estimating the molar concentrations of each 
drug which produced comparable degrees of 
contracture. The degree of contracture 
was measured as the number of mms. rise in 
height of the base -line on the drum. 
The activity was expressed as an 
equipotent molar ratio, i.e. the number of 
molecules of the drug which produced the 
same degree of contracture as one molecule 
of nicotine. 
The degree of contracture was 
measured for each drug at two dose levels and 
the response was plotted against the 
logarithm of the dose. The potency ratio 
was determined exactly as in the experiments 
on the rat diaphragm, and in a number of 
experiments a full four -point assay was 
performed. The equipotent molar ratio is 
the reciprocal of the potency ratio. 
All the tertiary compounds were tested 
on at least two chickens, but the 




The drugs were made up in isotonic 
saline and were added to the bath from a 
blow -out pipette. They were left in the 
bath until the degree of contracture had 
reached a maximum for the dose given. 
After washing out three times the muscle 
was allowed to recover for the same length 
of time as the drug was in the bath. 
Activity at Garlia:- 
The Cat Superior Cervical Ganglion Preparation 
(:Paton and Perry 1953 and Trendelenburg l954) 
The cats used were of either sex and weighed 
from 2 to 4 Kg. They were anaesthetised with 
ether in a box and were placed on a warmed table. 
The trachea was cannulated and was connected 
by a short tube to a Wolff bottle containing 
ether. The right femoral vein was exposed and 
cannulated and SOmg. /Kg. chloralose was given 
slowly in a 1% solution of saline at 33 °C. 
The cat's head was immobilised by securing 
the snout to a transverse bar placed between the 
jaws: this was firmly clamped to the table. 
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A thread was sewn into the right nictitating 
membrane. This was passed under a pulley and 
attached to a frontal writing lever. In a 
number of cats the responses from both the right 
and the left membranes were recorded. 
A length of the common carotid artery up to 
the external carotid was exposed. All the 
blood vessels excluding the lingual artery and 
the vessels supplying the superior cervical 
ganglia were cut between two ligatures. 
If the lingual artery was of sufficient 
diameter a Luer -lock syringe needle, adapted as 
a cannula, was inserted into it and the external 
and internal carotid arteries were tied off. 
A remote control bulldog clip was applied to the 
lingual artery between the needle and the 
carotid artery before cannulation. The needle 
was previously filled with saline and both the 
needle and the bulldog clip were securely 
clamped to the table. 
If the lingual artery was not big enough 
to be cannulated the external carotid artery was 
cannulated retrogradely instead in a similar 
manner to that described above. This time the 
internal / 
Fioure 13) 
CAT SUPERIOR CERVICAL GANGLION BLOCKADE 
!! !!!!!!!!!!!! !!!!R!!!!!!!!!! tut !!!!!!!!!!!!!!! 
TIME SCALE 30sees. 
jections Retrogradely into External Carotid Artery 
in 0.1m1 Saline 
N1 =100nM 
N_150nM NICOTINE 
P1 =-'OOnMi -CH2-NG 
P2 =300nM N diHBr 
S =0.1m1 Saline 
4.OKg Cat 
32Omg. Chloralose iv. 
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internal carotid and linguAl arteries were tied 
off. 
A length of the right preganglionic 
sympathetic nerve was separated from the vagus 
and was cut. The central end was laid on a 
pair of shielded platinum electrodes. 
A blood pressure record was normally taken 
by means of a mercury manometer with a cannula 
in the left femoral artery. Saline was used 
as the connecting; bridge and sufficient heparin 
was added to the saline at the tip of the 
cannula to prevent clotting. 
During the completion of the dissection 
small ouantities of saline were injected by means 
of a tuberculin syringe into the needle in order 
to prevent clotting. 
The nerve was stimulated maxima__ ly with 
square wave shoe b of O'. A 5 .secr ws. duration at :a 
rate of 10 per second and the contraction û'f tLe 
right nictitating membrane was recorded an a 
smoked drum. 
Method:- 
(i) Antagonist activity (i.e. the ability 
to produce gan,ylion block) was 
measured by estimating the molar 
concentrations of each drug nrhilch 
produced / 
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produced comparable degrees of block. 
The ganglion -block was measured as 
the relaxation of the nictitating 
membrane (in mms.) during maximal 
preganglionic nerve stimulation. 
The activity was expressed as an 
equipotent molar ratio (i.e. the 
number of molecules of the drug which 
produced the same blocs as one 
molecule of nicotine.) 
The equipotent molar ratio was 
determined exactly as in the 
experiments on the rat diaphragm. 
Four point assays were performed with 
a number of drugs and the activity 
of the others was determined 
graphically. Most of the compounds 
were tested on two cats, a few on 
three or four, and a few on only one 
.cat. 
M/10 stock solutions of the 
drugs in saline were stored at -2000. 
Doses were given close intra- 
arterially to the ;ganglion in 0.1 ml. 
from / 
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from a tuberculin syringe containing 
an appropriate dilution of the stock 
solution . 
Before each injection the needle 
was filled with the drub; solution to 
make sure no air bubbles were injected. 
After the effects of a dose had 
almost passed off an injection of 0.2ml. 
of saline was given. If this 
produced a response, indicating that 
the dose of drug had not all gone in, 
a further 0.2 ml. saline was injected. 
Doses producing between 10 and 
80% block were given and a time cycle 
was chosen which allowed complete 
recovery from the largest dose used. 
This period varied from 10 to 
30 minutes. 
(ii) Agonist activity was studied by 
observing rises in arterial blood 
pressure and/or contractions of the 
unstimulated nictitating membrane. 
Blood pressure records were 
taken / 
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taken in almost all the experiments 
with the cat superior cervical 
ganglion. These only gave rough 
indications of pressor or depressor 
activity. 
In a few instances the electrical 
stimulation of the preganglionic nerve 
was switched off and the ganglion 
stimulant activity was measured by 
observing the contraction (in mms.) 
of the nictitating membrane produced 
by doses of the drugs. 
An equipotent molar ratio was 
evaluated either by a four -point assay, 
or, more usually, graphically as in 
the experiments on the rat diaphragm. 
Activity on Cholinesterase 
Enzyme Source: - 
The Cholinesterase used was the enzyme 
present in dog caudate nucleus which is regarded 
as an acetylcholinesterase. (Mendel et al 1943; 
Sturge and Whitaker 1950) . 
An / 
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An acetone powder was prepared from the 
caudate nuclei of five dogs which had been 
anaesthetised with thiopentone and bled out. 
The brains were removed within 30 minutes of death 
and the caudate nuclei were removed and stored at 
-20 °C. overnight. The nuclei were homogenised 
in ice -cold acetone with an "Atomix" blender. 
The acetone was filtered off and the residual 
powder was washed several times with cold acetone, 
dried in vacuum over calcium chloride, and stored 
at room temperature over calcium chloride. 
When required for use a weighed portion of 
this powder was homogenised by hand and was 
suspended in Krebs' bicarbonate buffer solution. 
Method: - (Ammon 1934) 
(a) Control Experiments 
The rate of hydrolysis of the 
substrate acetylcholine, was followed 
manometrically at constant volume and 
at 37 °C. by observing the evolution 
of carbon dioxide from Krebs' 
bicarbonate buffer by the acetic acid 
produced. 
The reaction was performed in .an 
atmosphere of 5% carbon dioxide 95% 
nitrogen in a constant volume 
manometer. / 
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manometer. This instrument is a 
modification of the "blood -gas 
manometer" described by Barcroft and 
Haldane (1902) . 
Control experiments were first 
performed showing the hydrolysis of 
acetylcholine in the absence of any 
inhibitor. The effects of substrate 
concentration on the rate of 
hydrolysis were studied using various 
amounts of acetone powder. The 
purpose of these experiments was to 
establish the minimum amount of 
acetone powder which could 
satisfactorily be used and the degree 
of saturation of the enzyme produced 
by particular concentrations of the 
substrate. 
Flasks were prepared as follows: - 
I Thermobarometer - containing 
water only. 
II Blank - containing buffer, 
acetone powder, but no substrate. 
III - XII Test flasks containing 




EXPERIMENT 18/10/60. 6mg ACETONE POWDER /FLASK. SUBSTRATE CONCENTRATION FROM M /100 -M /4000 
Gassed 10minutes with 5°/. CO2 95 ° /.N2 Equilibrated 15minutes at 37'C. Substrate made up in KREBSI bicarbonate buffer 
FLASK NUMBER THERMO- 
BAROMETER 
( new 5) 
. BLANK . 
(oldl) 
. M /100 Ach 
(old2) 








M /4000 Ach 
(old9) 
MAIN FLASK 
1 Suspension of powder 0-6m1s. 0.6mis. O.6mis. 0-6mts. 0.6 mis. O.6mis. 0.6m1s, 
2Buffer 6m1s.Water 5mis.Krebs' 3m1s Krebs' 3.2m1s.Krebs' 33m1s Krebs' 48mIs.Krebs' 7.Omts.Krebs' 7.2mIs. Krebs'. 
SIDE BULB _ 04 ml. Water 04mLM /10 Ach. 0.2 ml. M /10Ach. Olml.M /10Ach.0.6ml.M /100Ach 0-4ml.M /IOOAch. O.2mt.M /IOOAch. 
Substrate 
8mis. Smis. TOTAL VOLUME 6m1s 6mIs. 4mis. 4m1s. 4mIs- 6rnls. 
ABSOLUTE AMOUNT Ash - 40 NM 20p 10NM 6pM 4p 2NM _ 
THEORETICAL 
EVOLUTION of CO2 896p1 448w1 224p1 134.4pí 89 6p1 44.8p1 
FLASK CONSTANT KCO2 2.02 1.83 1.97 2.01 1.90 1.94 1.77 
a 
INITIAL READI NG - 48 -64 
- 
-73 -84 -87 -50 -86 -36 
3 Minutes -49 -1 -67 -2 -4 -68 +66 t11 +15- 79 +6 +12 +16 82 +6 +12 +16-45 +6+ - 11 +15- S4 +3 +6 +10 35+2 +4 + 8 
6 Minutes -49 -1 -67- 2 -4 -64+10+18 +22-74411 +22 +26-77 +11 +22 26- 39+12 +23 +27- 79 +8 +16 +20 -31 + 6 +11 +15 
9 Minutes -49 -1 -67 -2 -4 -57 +17 +31 +35-68+17 +33 +37 =70 +18+36+40 33 + 18 +3468 -75 +12 +23 +27 -28 +9 +16 +20 
12 Minutes -49 -1 -66 -1 -2 -52 +22- V40+42-62 +23 +45 +47- 65+-23446.48 28 #23 +44 +46-70 +17 +33135 -24+ 13 +23 +25 
13 Minutes -48 -0 -65 - 1 -2 -47 +26 + 48 +50- 57+27 +53 }55-60 +27 +54+56 -24 + 26 +50+52-67 t19 +37 +39 -22 + 14 +25 +27 
20 Minutes -48 -0 -65 -1 -2 -38 +35 -' 64 +66 -48 +36 +71 +73 -52 +35 +702 -1 7 + 33 + 63+65 -61 +25 +49 +51 -19 + 17 +30 +32 
25 Minutes -49 -1 -66 -1 -2 -29 +45+82 +84-39 +46 +91+93-43 +430092 - 9 + 41 +78.80 -56 +31 +60 +62 -18 t 19 +34 +36 
30 Minutes -49 -1 -66 -1 -2 2 1 +53 X97 +99 31 + 54+1064106-36+52+1054107 -3 + 47 +89491 -52 +35 +68 +70 -15 t 22 439 + 41 
From Graph Evolution CO2 
5 -.15 mins. 31 3 4 34 33 26 18 




EXPERIMENT 18/10/60. 6 mg. ACETONE POWDER 
GRAPH of CO2 VOLVED(L.)/DURAT ION of HYDROLYSIS (mins.) 
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DURAT ION of HYDROLYSIS (mins.) 
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Such an experiment is shown in 
Table 2 and Graph I . The 
rate of evolution is measured from the 
initial slope (5 to 15 minutes). 
Notes:- 
1. It is essential to make up the 
acetylcholine in buffer 
immediately before used. If it 
is made up in distilled water the 
solution is distinctly acid and 
will cause an evolution of carbon 
dioxide from the Krebs' solution 
on tipping. 
2. The flasks were gassed with 5% 
carbon dioxide, 95% nitrogen for 
5 to 10 minutes and were 
equilibrated at 37 °C. for 15 
minutes before tipping. 
3. Additional blanks containing 
acetone powder and buffer but no 
substrate were added if the blanks 
appeared to be erratic. 
4. The total amount of substrate 
present was such that the 
substrate would not be all 
exhausted. 
Table 7 
Relationship between Rate of hydrolysis 




yl. Carbon dioxide evolved /30 mins. at 
different substrate concentrations 
0.01M 0.005M 0.0025M 0.001M 0.005 0.00025 
3 mg 50 55 55 50 40 30 
4 mg 60 66 66 60 46 33 












¡RATEGRAPH OF SUBSTRATE CONCENTRATION 
OF HYDROLYSIS (uLitreCO.2)30mins) 
40 3O 2.0 
LOG. MOLAR CONCENTRATION SUBSTRATE 
S8)- 6mg Tissue 
X - 4 mg Tissue 
= 3 mg Tissue 
1.0 
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The results of these experiments are 
shown in Table 3 and Graph II. 
(b) Test of Inhibitors: 
From these results it was decided 
to test the inhibitors on the 
hydrolysis of 10 -3 acetylcholine by 
L. mgs. of acetone powder. The total 
volume of fluid in each flask was 
6 mis. 
The concentration of inhibitor 
which produced 50% inhibition of the 
hydrolysis of this concentration of 
acetylcholine was determined, and log 
of the reciprocal of this, the p150 
was used as an index of inhibitory 
activity. 
The flasks were set up as follows: - 
I Thermobarometer - containing 
water only. 
II Blank - containing buffer, 
acetone powder, but no substrate. 
III / 
EXPERIMENT 8/12/60 4-mg. ACETONE POWDER /FLASK. INHIBITOR ACTIVITY 
Gassed 1Ominutes with 5 ° /.CO2 95'/.N2 . Equilibrated 15minutes at 37C . 
Substrate made up in KREBS bicarbonate buffer . 
M /1000 Acetylcholine in each flask. - Total Volume 6mis- Maximum evolution of 



























°etD M /500 
(old11) 
/3et M /500 
(old 12) 





0.4m1s. 0.4m1s. 0.4m1s. 0.4m1s. 0.4m1s 0.4mIs. O-4m1s. 0.4m1s. 0.4m1s. 
2. Buffer 53m1.Krebs' 4.7m1.Krebs'53m1.Krebs' 4.7ml.Krebs' 4.7ml. Krebs' 53ml.Krebs: 4.7 ml. Krebs' 4.7ml,Krebs' 4.7 ml. Krebs' 
3. Inhibitor 6mlwater 06mI.M /500 0.6 ml. M /500 ! 06ml. M /500 O-6m1. M /50 0.6m1. M /50 0.6m1. M /50 
oCe t D ocetD /.3 et ocetD /3 et /.3et 
SIDE BULB 0.3m1. 0.3m1. 03ml. M /50 0.3m1. M /50 O.3ml. M /50 O.3ml. M /50 0.3m1.M/50 0.3m1.M /50 0.3m1. M/50 
Substrate water water Ach. Ach. Ach. Ach. Ach. Ach. Ach. 
FLASK 
CONSTANT K.CC, 2.02 1'91 1.78 2.00 1.83 1.55 1.88 2 -09 1.91 
INITIAL 
READING - 50 -76 -86 -87 -65 
l 
54 - -79 -55 -66 77 
3 Minutes -49 +1 -76 -1 -2 -87 -2 -4 -87 +1 +2 +4 -63 + 1 +2 +6 -52 +1 +2 +6 -77 +1 +2 +4 -54 +0 +0 +4 -65 +0 +0 +4 -76 t0 +0 +4 
6 Minutes - 50 + 0 -75 ti +2 -86 +0 +0 -83 +4 +7 +5 -61 +4 +8 +8 -50 1 4 +7 t 7 -74 + 5 +8 t 6 -53 +2 +4 + 4 -64 t2 +4 +4 -75 +2 +4 +4 
1C Minutes - 49 + 1 -76 -1 -2 -84 +1 +2 1-80 +6 +1l +13 -59 4- 5 +10 +8 -46 +7 +13 t11 -69 t 9 114 +16 -52 12 +4 +2 -62 +3 -t-6 +4 -72 ..4 +8 +6 
15 Minu + e s ,- 504- 0 -75 t1 t2 -85 +1 +2 -76 +11 +20 +18 -58 +7 +14 +12 -43 t11 +20 118 -65 +14 122 +20 -51 +4 + 8 +6 -59 + 7 +15 113 -70 + 7 +13 +11 
.. Minu; es I- 5C+ O -75 +1 t2 -85 +1 +2 -72 +15 +27 +25 -57 +8 +16 +14 -41 +13+24 +22 -60 +19+29 +27 -51 +4 +8 t6 -58 +8 +17 115 -68 +9 +17 +15 
25 Minutes - 51 - 1 -76 t1 42 -8 4 +3 +6 -69 119 +34 +32 -56 +10 42014 4 F-37 +18 +33 +27 -56 4-24437 +35 -52 + 4 + 8 + 2 -56 +11 23 +17 -66 - 12 +23 +17 
30 Minutes -52 -2 -77 +1 +2 -86 +2 +4 1- 65424 +43 441 -54 413 +26+22 r34 +22 +40 +36 -52 429+45443 -51 16 +11 +7 -54 411 
+29 +25 -64 +15 +29 +25 
i- -,m Graph 
Evoiu;ion CO2 
_5- 1 5mins 15 7 14 2 7.5 7.5 
X 3 = 30mins 45 21 42 6 22-5 
22.5 
50' /. 
°'° (r.r .h ition - 53'6 7 °/° 87 °/° 50'4' 
GRAPH III 




ocetD_ 1.6x10 -4M / , 9 e t D = 2.O x 10 - M 
4.0 3.0 
LOG. INHIBITOR CONCENTRATION 
2.0 
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III Control - containing buffer, 
acetone powder, and substrate. 
IV Inhibitor Blank - containing 
buffer, acetone powder, inhibitor, 
but no substrate. 
V Inhibitor Test - containing buffer, 
acetone powder, inhibitor and 
substrate. 
Notes: - 
1. The concentration of inhibitor 
used in the inhibitor blank was 
the highest used in the test 
flasks. 
2. The inhibitor was placed in the 
main flask with the acetone powder 
and buffer and the substrate in 
the side bulb. 
Tye 
3. Fresh /10 solutions of drugs 
in deionised water were prepared 
for these experiments. 
A typical experiment is shown in 
Table L. and Graph III shows how 
the p150 was obtained from the 
initial rates of evolution expressed 
as / 
Table 5 
Determination of Ks 
Tissue v ::olar con c . 
Ach. S 1/s 
ate of 
hydrolysis 
1 CO min 
1/v 
3 mg 0.001 1000 1.7 0.60 
0.0005 2000 1.3 0.75 
0.00025 4000 1.0 1.00 
4. mg 0.001 1000 2.0 0.50 
0.005 2000 1.6 0.63 
0.00025 4000 1.1 0.91 
6 mg 0.001 ; 1000 3.3 0.30 
0.0005 2(0)0 2.6 0.38 
0.00025 4000 1.8 0.56 
GRAPH IV 
GRAPH of 1Ñ/ : DETERMINATION of Ks GRAPH 
-3000 -'2 000 -1 000 1000 2000 3000 4000 
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as a percentage of the control rate 
(non- inhibited) . 
Comment: - 
After all the experiments had been done 
it was realised that this was not a very good 
way of expressing inhibitory activity. The 
valve of p150 will vary with the substrate 
concentration used. The relationship is 
given by :- 
1 + 
S 
/Ks = I /Ki - Equation (1) 
where S = substrate concentration 
I = inhibitor concentration 
Ks = dissocation constant of 
Enzyme - substrate 
complex 
Ki = dissociation constant 
of the Enzyme - 
inhibitor complex. 
It would be much better to measure the Ki 
which will be a true constant (at 37 °C). 
Fortunately this can actually be estimated 
because Ks (the Michaelis Constant) can be 
obtained from the results in Table 5 
Graph IV shows how Ks is obtained from 
these results by the method of Lineweaver 
and Burk (1934) . 
The / 
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The intercept gives a value for 
1 
- /Ks = -2900 
Hence Ks = 3.45 x 10 -4 
From equation (1) 
-log Ki = pI50 + log (1 + S /ris) 
= p150 + log (1 + 10-3/ 
3.45 x 10 -4) 
= p15o + log 3.9 
. . In these experiments 
- log Ki = p150 + 0.59 
A much simpler method of finding Ki 
is that of Dixon (1953) in which the 
inhibition is studied with a series of 
inhibitor concentrations at two substrate 
concentrations and 1/v is plotted against 
i (v = rate of hydrolysis, i = inhibitor. 
concentration). The intersect of these 
two lines gives -Ki directly. 
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Measurement of Dissociation Constants. 
The pKa values of the nicotine analogues were 
found by potentiometric titration after the 
method of Goldacre and Albert (1943). 
10 mis. of an 
tu. 
/100 solution of the 
hydrobromide or dihydrobromide of the drug in 
deionised water was titrated with standard 
alkali by means of a glass electrode placed in 
the solution and connected with a Marconi 
pH Meter (Type 'T. 511D) . The other half of the 
cell was a calomel electrode connected to the 
solution by a potassium chloride bridge. The 
solution was continuously stirred by a áuickfit 
compressed air- driven stirring rod (PSU8/0) and 
was maintained at 25° 
+ 
0.1 °C. in a water bath. 
The dissociation of the salt is:- 
BH+B+H+ 
LBJ 
whence Ka = (neglecting 
511.27 activity 
coefficients) 
and at half neutralisation 
CBJ = LB11:47 
. at half neutralisation Ka = 
pKa = pH 
The pKa values of the dihydrobromides were 
therefore / 
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therefore taken as the pH of the solution after 
the addition of 0.5 and 1.5 mis. of i/l0 sodium 
hydroxide solution. In the case of the mono- 
quaternary compounds there can only be one pKa 
value. 
In two instances the hydrobromides were not 
available: nicotine monomethiodide and nicotine 
hydrogen tartrate. 
The nicotine monomethiodide was titrated 
against an equivalent amount of standard 
hydrochloric acid. Nicotine hydrogen tartrate 
was converted to the base by passing it down a 
column of I.I.A. 400. The effluent was 
titrated against standard hydrochloric acid and 
the pH curve was plotted. An equivalent of 
standard sodium hydroxide was then added and 
the curve replotted. From these two curves the 
pKa values were found. 
The corresponding pKa values at 37 °C. are 





QH 1 1 
log 
4.570 
/Tl - /T2/ 
Thus if the dissociation constant of a 
compound is known at two temperatures dH can be 
calculated, and this may be used to find values 
of/ 
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of pKa at other temperatures. 
This was not considered necessary as it 
appeared that the approximate correction 
suggested by Albert (1960) was sufficiently 
accurate for our purposes. He noted that for 
weak bases a correction of -0.011 of a pH unit 
should be made for each C. rise in temperature, 
and that for strong bases at correction of 
-0.022 was necessary. 
The values found for the second pKa value 
of nicotine at two temperatures are: - 
8.11 at 20 °C. - Taylor (1951) 
and 8.01 at 25 °C. - see results section, 
i.e. a fall of 0.02 units for each °C. rise in 
temperature. 
The pKa at 37 °C. was, in these experiments, 
calculated by subtracting 12 x 0.02 (i.e. 0.2L1) 
from the value at 25 °C. 
From the value of pKa it was possible to 
calculate the percentage ionised form present 
at physiological pH and temperature, 
( ionised 100 
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RESULTS 
Activity at the Neuromuscular Junction:- 
I The Rat Phrenic Nerve - Diaphragm Preparation: - 
The neuromuscular blocking activity of the 
compounds tested on this preparation is 
summarised in Table 6 and Graphs V an.dVI 
In the table the compounds are listed in order of 
activity. 
The most active compound is Y- pyridyl 
methyl trimethylammonium bromide hydrobromide 
which is about 16 times as active as nicotine. 
Other compounds with high activity are ft -pyridyl 
methyl methylpyrrolidinium bromide hydrobromide, 
-pyridyl ethyl trimethylammonium bromide hydro - 
bromide, and nicotine monomethiodide which are 
approximately 13, 10 and 9 times as active as 
nicotine respectively. On this preparation 14 
out of 30 analogues of nicotine were more active 
than nicotine. 
The quaternary compounds appear to be more 
active than the corresponding tertiary bases. 
Of the tertiary bases the )3 compounds appear to 
be more active than the corresponding oL and Y 
compounds although the 44-pyridyl ethyl pioeridine 
and pyrrolidine dihydrobromides are exceptions. 
These compounds are 2.3 and 1.0 times as active 
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II The Chick Biventer Cervicis Preparation: - 
The activity of the compounds in producing 
contracture of the chick biventer cervicis 
preparation is summarised in Table 7 and 
Graphs VII and VIII. In Table 7 the compounds 
are listed in order of activity. 
The only compound tested which is more 
active than nicotine (3.6 times) is /3 -pyridyl 
ethyl trimethylammonium bromide hydrobromide. 
Quaternisation of the dimethylamino side chain 
leads to an increase in the activity but 
quaternisation of heterocyclic substituents 
appears to have no effect on activity or may 
decrease activity, eg. nicotine monomethiodide is 
0.8 times as active as nicotine and /3 -pyridyl 
methyl methylpiperidinium bromide hydrobromide is 
0.07 times as active as its tertiary analogue. 
In the tertiary series the /3 compounds are 
more active than the corresponding oL and 
compounds with the exception of of -pyridyl ethyl 
piperidine dihydrobromide. 
GRAPH IX 
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Activity at Ganglia 
The Cat Superior Cervical Ganglion: - 
(a) The blocking activity of the compounds on 
the cat superior cervical ganglion is 
summarised in Table 8 and Graphs IX and X 
In Table 8 the compounds are listed in order 
of activity. 
The most active compound is /3 -pyridyl 
ethyl trimethylammonium bromide hydrobromide 
which is 16 times as active as nicotine. The 
only other compounds which are more active than 
nicotine are %3 -pyridyl methyl pyrrolidine 
dihydrobromide and /3 -pyridyl methyl 
trimethylammonium- bromide and hydrobromide which 
are both about 1.4 times as active as nicotine. 
Quaternisation in the dimethylamino series 
increases activity whereas quaternisation of a 
heterocyclic side chain nitrogen always decreased 
activity. For example nicotine monomethiodide 
is 0.23 times as active as nicotine. 
In both the tertiary and quaternary series 
the /3 compounds are more active than the 
corresponding oC and )/ compounds. 
Table 9 
Stimulant _Activity on Ganglion 
Observation on Nictitating Membrane 
Equipotent Molar Ratio 
CoKnPovnd Exp. 
Stimul a n t Blocking 
C3NZ-6D'CH; C ' t443 1(b) 25 17 
G-- ,c oi3 
042"01 
l.cH3 1( a) 400 400 
ef-' 
c142,-cm,-0 1(a) 30 54 
.---- 
c142-042-im 1(a) 33 52 
.---- 
t o 2-coz-N 
S.--_ 
1( a) >800 330 
; 1.42-cKZ_N 1( 




1(a) 2.4 2.9 
4 .c4i; 
c1-1171t7 cH3 
N C H3 
1(a) 0.5 0.73 
cai-Ñ cÑ; 
s tyi 
1( a) 1.3 9.3 
e''' 
Ñ 
` K' C4s t 4t3 1(b) 3.5 4.3 * 
` `-- 
1t LNS p-cHi cHi-tM-ce; 1(b) C 4j? 0.13 0.49 
-4 .c4 
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The Cat Su erior Cervical GanFrlion 
(b) The stimulant activity of a few of the 
compounds is summarised in Table 9. In all 
of the other compounds tested only a qualitative 
estimate of stimulant activity was made. 
All the compounds tested (apart from two) 
produced, in doses which caused ganglion. block, 
an initial stimulation of the ganglion as shown 
by a rapid contraction of the nictitating 
membrane. The only two compounds which failed 
to stimulate were/3-pyridyl methyl 
methyldiethylammonium bromide hydrohromidc and 
homocholine phenyl ether. 
Insufficient quantitative estimates of 
stimulant activies were made to warrant any 
conclusions being drawn fróm these results 
although it is interesting to note that for the 
quaternary compounds tested the stimulant 
activity compared to nicotine was greater than 
the blocking activity found. 
Table 10 . 
Anticholinesterase :...ctivity: Inhibitor Constant Ki 
Tertiar.1- Combounas 
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'. CO2 C 
3 1.99 3.29 5.13 x 10-4 (Ms- t4 
cH3-0C--- 3 8.96 2.64 2.29 x 10-3 
m 
cHt- V I 17 2.42 3.21 6.17 x 10- 
O 
cHL- /.4 3.51 3.04 9.12 10-4 
cHt 3 5 38 3.26 5.50 x 10-4 
vii All 
CH% ".Ncti s 
2 2.31 3.23 
-ft 
5.89 x 10 ' 
eCNI CHI- N 
`CPIs 
2 8.99 2.64 2.29 x 10 -3 
01; 
cHs- N.,cH3 2 1.58 2.63 x 10 
-2 
cil1-cHI:4C, 2 O.27 4.18 6.61 x 10 
1 C H i - CHI' Pa 2 9a.6 1.61 2.46 x 10-2 
ciit-cHt-N 2 5.53 2.85 1 . 41 x 10-3 
cs4.-cH2-N1 3 1.42 3.44 
-4 3.63 
lolp c..c.v. m 
3 2.37 3.22 6.03 
3 4.19 2.97 1.07 x 10 - 
-7, CO:. C H2' M 
ecti3 
col- trti.-N- cfrt) 
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f Chl'et17 - N:CcHol; 2 
4.55 2.93 1.18 x 10-5 
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-ctil 



















0-7) c cM 
2 2.5 3.19 6.5 x 10-li 
+/- 
JC$z-N CH \-- 
2 2.7 3.16 7.0 x 10-4 
NN tNl-N;gñ3 2 
3 
15G 1.41 3.9 x 10-2 
N tNtfl-N.cH 
2 
: :  6.o 2.c1 1.5 x 10-3 
cN tM -Ñ'cHs : s cH; 
N. Ka 
1 300 1.11 
, 
7.6 x lo 
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Activity on Cholinesterase: - 
The anticholinesterase activity of the 
compounds on dog caudate nucleus is summarised 
in Tables 10 and 11. The right hand column 
in the tables gives an estimate of the Inhibitor 
Constants (Ki) calculated by the method 
described above. 
In general the PC compounds are more active 
than the corresponding /3 and Ó compounds. 
The most active compound isoC- pyridyl ethyl 
dimethylamine dihydrobromide. The five most 
active compounds are numbered at the extreme 
right of the table in order of activity. In 
general the ethylene- linked compounds are more 
active than the corresponding methylene -linked 
compounds, (especially in the oL series). 
The five quaternary compounds tested are 
less active than the corresponding tertiary 
compounds. 









9*26 gg2 622 zg° 
996 992 0176 tV17 14..943-tviz 
17176 T99 ;9 9 T..-°17 
T°36 60°6 CC*6 g9*(,-. 
N_ND.-s14, 
o,,3E Lo0C--. -E°6 Ti__*17 D-1.14,-111,04 
D4-114-3-44, I n.(- N6 -eC* 6 t_-17 
Ir,(3E EVE Cti6 99C ny-114,-Lii 7 --I 
9-17 9-17°L OL*2_ gt1(2 90. 
1767,2_ ovL t7O .(z.-' C 





299 992_ 6'i. 96*,c_ '442 
0179 a-L*9 
0 
17'69 Te9 Gg*g 2.9*z 
o 
NJ -114, 
a 96'L oz*9 717.(-: 
-- 
L.' G2 9Vg oft° 2 ,r) D "s14) % 
g'06 9°G' 099 o9* -go2 
I 




















spunoovo,n L..11-3T;JGI Jo uoT=vesTuoT pue STA -eHci 
Table 13 
pKa Values for Pyridine Nitrogen 
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Dissociation Constants 
The dissociation constants of the compounds 
expressed as the pKa's at 25 °C are summarised in 
Tables 12 and 13 and Graph XI. 
The pKa value of the pyridine nitrogen 
increases as the substituent is moved from the 
to the /3 to the ' position in both 
tertiary and quaternary compounds of the 
methylene and ethylene series. These results 
suggest that the presence of the charge on the 
side chain nitrogen increases the dissociation of 
the proton from the pyridine nitrogen and hence 
the at., compounds are weaker bases than the A 
compounds which are weaker than the is 
compounds. The increase in base strength as 
the chain length separating the side chain 
nitrogen from the pyridine ring is increased 
from methylene to ethylene gives further support 
to the above hypothesis. 
In the ethylene series there is no regular 
pattern observed in the pKa values of the side 
chain nitrogen. In the methylene series, 
however, with the three nitrogen substituents 
tested there is a decrease in the pKa value as 
the side chain is moved from the aG to the /3 
to the 0 position. This increase in base 
strength / 
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strength as the side chain nitrogen approaches 
the pyridine nitrogen may be due to the presence 
of a negative charge on the pyridine nitrogen. 
(Longuet- Higgins and Coulson 1947) . Such a 
negative charge may attract a proton and assist 
its binding to the side chain nitrogen if this 
is close (as in the d position) and thus may 
cause an increase in the base strength of the 
side chain nitrogen. 
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DISCUSSION 
I Significance of the Results: - 
Type of Action on the Rat Diaphram: 
Activity has been studied at two types of 
site, the neuromuscular junction and the 
ganglion. 
In the rat diaphragm test a block of 
conduction could be brought about (setting aside 
an interference with the release of transmitter) 
by an action like curare or by an action like 
decamethonium. From the account in the 
introduction it seems reasonable to regard the 
action of decamethonium as being one of 
desensitisation associated with a brief 
depolarisation. A measure of ability to 
depolarise should be provided fairly reliably 
by the contracture produced in the chick 
biventer test (allowance being made for species 
differences). This may give some indication 
of the ability to produce a desensitisation 
block and, if this is true, differences between 
activity in the chick biventer test and in the 
rat diaphragm test might be taken to indicate 
differences in the way neuromuscular block is 
produced. / 
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produced. For example -pyridyl ethyl 
piperidine and pyrrolidine dihydrobromides are 
virtually inactive in the chick biventer test 
and yet are comparable in activity with nicotine 
in the rat diaphragm test: this suggests a 
curare -like action on the rat diaphragm. 
Type of Action on the Cat Ganglion: 
In ganglia (again setting aside interference 
with the release of transmitter) two types of 
action are possible, a block like hexamethonium 
(apparently competitive) and a block like 
acetylcholine or nicotine (apparently one of 
desensitisation). Some indication of the 
ability to desensitise might be provided by the 
ability of the drug to cause contracture of the 
unstimulated nictitating membrane. This was 
not studied systematically but the information 
available (Table 9) suggests that most compounds 
do this and are probably acting like nicotine. 
Although it is very doubtful whether the results 
with the chick biventer can be expected to 
indicate ability to desensitise the ganglion, 
there is in fact quite good agreement between 
the two preparations (Tables 17 and 18). 
Possibility of an Indirect Action: 
Anticholinesterase Activity; 
In all these tests the possibility of an 
indirect action by blocking cholinesterase must 
be / 
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2.77 4.16 1.60 2.64 
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/CH; 
CHI- N,cH3 2.65 3.10 0.21 1.58 
/ 
¡ c141-cHt.-N 3.70 3.81 1.08 4.18 
1 cH:-cN=-1,4 
3.69 3.94 1.10 1.61 
N 
cNz cHs N 3.37 L 2,0 0.30 2.85 
i 
N cNs- cHS-N 4.06 4.26 1.04 3.44 
cNz-cNs-N 
3.88 4.07 1.12 3.22 
Citi-cN,,-K 3.54 4 1.83 0.26 2.97 
0 H,-cr+3-N.H; 2.49 3.60 0.99 4.32 
V 
cHt-cH=-N.cH; 
`cH3 2.77 4.05 2.35 2.93 
c,-cN,-Ñ,cH3 ' N 
c a 
2.35 2.57 0.44 2.58 
Table 15 Com.arison of Effective Concentrations 
Quaternary Compounds 
N ! 









4.66 5.54 2.18 3.19 
coi-,14 4.82 5.43 2.37 3.16 
+ tot-N 
cos 
3.87 4.21 0.81 - 
t iC3 `N CNs-N. N 2.99 3.86 1.01 1.41 
c,N:cÑ; 
.hl cKS 
4.43 5.60 2.95 - 
OrMsN clN1LF.12 
NtcN; 
4.94 1.8L. - 
Ir eK: c N3 3.51 L. 21 1.62 - 
8 
4.89 5.60 1.58 - tri ca=-Ñ 
Ca / 
4 / CN3 N Ì Ni-CNiN4:3 2.99 3.86 1.20 2.81 
cH=CNiÑ _cots N1 cos 4.70 6.15 L.o3 1.11 
CHI, 
4.11 4.98 1.35 - 
* CH=-eK; * (cH3 M-cil 
'CK3 
4.21 4.66 1.67 - 
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be considered. A comparison is made in Tables 14 
and 15 
between the concentrations of the compounds 
effective on the three preparations and 
cholinesterase from dog caudate nucleus. It 
appears that anticholinesterase activity is 
really only likely to affect the pharmacological 
response in the rat diaphragm. None of the 
quaternary compounds tested is likely to block 
cholinesterase to a significant degree in the 
concentrations used in the pharmacological tests. 
The results in the ganglion experiments are 
more difficult to analyse because the effective 
concentration at the ganglion is unknown. As 
will be seen in Table 14 in these experiments 
the 0.1 ml. of a 10 -2'31M solution of nicotine 
produced roughly 50% block. This can hardly be 
the concentration at the receptors because, if 
it were, a considerable block of cholinesterase 
should result and experiments do not support the 
idea that the ganglion blocking action of nicotine 
is accompanied by any appreciable block of 
cholinesterase. With the a- substituted 
pyridyl compounds, however, the figures for the 
injected concentration and effective anti - 
cholinesterase concentration differ by almost 
1000 / 
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1000 and the type of response (long duration) 
suggests that these, at least, are affecting 
cholinesterase in the experiments. If the 
distribution of the difference between -log Ki 
and -log C50 is plotted (Graph XII) it will be 
seen that 5 oC compounds, 4 ó compounds, and 
1 /3 compound have values between -2.0 and 
-3.5 and 6 /3 compounds, 1 cC compound and 
2 ó compounds have values between -1.99 and 
-0.00. The quaternary compounds for which the 
figures are available (2 /3 compounds and 2 oC 
compounds) all have values between -1.61 and 
-0.40. (Table 16). 
The compounds in which the difference lies 
between -2.0 and -3.5 appear to be either the 
tertiary compounds which are only feebly 
active and so must be given in a higher 
concentration, or the aC compounds whose 
anticholinesterase activity is greater than that 
of the ß and 2( compounds (Table 10). It 
might be supposed, therefore, that the dilution 
factor is of the order of 100 but this is 
clearly only a guess. 
Active / 
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Active Species: Ion or Salt: 
Before relationships between structure and 
activity can be discussed it is important to 
consider whether it is the ion or the base (or 
both) which is active. This could be settled 
by studying the effect of pli on activity. This 
has not been done (as yet) but some indication 
of which is the active species is given by 
considering the degree of ionisation of the 
various compounds at the pH of the test (7.38). 
All the compounds are mostly in the form of 
the univalent ion in which the proton is 
attached to the side chain amino group. Even 
the compound with the least basic side chain 
amino group ( Sr -pyridyl methyl dimethylamine 
dihydrobromide) is over 50% ionised and most of 
the compounds are round about 90% ionised (Table 
12, Graph XI). In contrast the pyridine 
nitrogen atom, even in the most strongly basic 
compound ( j( -pyridyl ethyl piperidine 
dihydrobromide) is at most 0.25% ionised. This 
coupled with the activity of the quaternary 
compounds strongly suggests that it is the 
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+ tH3 cNs' ctt 
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.a , ois 
C42-62,-coo- 
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Ctis 
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is true the pharmacological activities ought to 
be expressed in terms of the ion and in 
Tables 17 and 18 the results are set out, 
for comparison with the activity both as the ion 
and as the total salt. In fact the activity 
per ion is not greatly different from the 
activity per molecule of salt. 
Table 19 Methylene Series 
Activities of 0( and 1( compounds relative 
to /3 compounds:- 
(a) per ion 
Side 
Chain 
Rat Diaphragm Chick Biventer Cat Ganglion 
PL ß ó' at ó oc- A v 
, c 14 
0.21 1.0 1.0 0.04 1.0 0.11 0.14 1.0 0.05 
"H(--) 0.2 1.0 0.16 0.05 1.0 0.04 0.05 1.0 0.01 
0.1 1.0 0.39 0.02 1.0 0.08 0.006 1.0 0.02 
4 eCiil 
N ; H3 
HS 
0.04 1.0 2.8 ; 0.02 
, 
1.0 1.0 0.01 1.0 0.04 
(b) per total salt 
Side 
Chain 
Rat Diaphragm Chick Biventer Cat Ganglion 
ok /3 o( /3 ó ac /3 ó 
Nj ~ ctt3 0.23 1.0 0.76 0.04 1.0 0.09 0.15 1.0 0.04 
NO 0.22 1.0 0.12 0.06 1.0 0.03 0.06 1.0 0.01 
. Ñ 0.11 1.0 0.36 0.02 1.0 0.08 0.006 1.0 0.02 
-t4Z 3 
cN 
0.04 1.0 2.8 0.02 1.0 1.0 0.01 1.0 0.04 
Table 20 Ethylene Series 
Activities of °4- and Y compounds relative 
to l3 compounds:- 
(a) per ion 
Side 
Chain 
Rat Diaphragm Chick Biventer Cat Ganglion 
C4 A ó o' ß Y at- A Ó 
- p3 
H 3 
0.52 1.0 0.39 0.37 1.0 0.03 0.04 1.0 0.01 
-ro0 1.50 1.0 0.46 1.8 1.0 0.00 0.80 1.0 0.13 
-Ñ 1.0 1.0 0.48 0.75 1.0 0.00 0.96 1.0 0.16 
. N ctt3 .c.343 0.02 1.0 - 0.005 1.0 - 0.001 1.0 -- 
(b) per total salt 
Side 
Chain 
Rat Diaphragm Chick Biventer Cat Ganglion 
oL /3 ( o'- ß I( vC !3 t 
14 ' 
CN3 
tb3 0.52 1.0 0.38 0.36 1.0 0.03 0.04 1.0 0.01 
-N 1.50 1.0 0.46 1.80 1.0 0.00 0.83 1.0 0.14 
1.0 1.0 0.48 0.76 1.0 0.00 0.96 1.0 0.16 
4e(Ks 
- ti-c %3 
thl 
0.02 1.0 - 0.005 1.0 - 0001 1.0 -- 
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II Relationships between Structure and Activity 
From Tables 17 and 18 it should be possible 
to see whether the results support the hypothesis 
that nicotine -like activity is associated with a 
partial positive charge at a suitable position in 
the molecule. 
(a) The Effect of Position of the Side Chain - 
If the charge were that located on the 2 or 
the 4 carbon atoms in the pyridine ring, it would 
be expected that the A compounds should be more 
active than the oC or the 1( isomers. Tables 
19 and 20 show the activity of the d. and the 
compounds expressed in terms of that of the 
A compound. :Without exception in the series 
of pyridyl methyl dialkylamines the )3 isomer is 
the most active. This is shown most clearly in 
the experiments on the chick biventer and cat 
ganglion. On the rat diaphragm the differences 
between the activity of the isomers are not so 
great. 
In the series of pyridyl ethyl dialkylamines 
activity is maximal at the %3 isomer of the 
dimethylamino series but in the two other series 
examined considerable activity is also found on 
all preparations with the d- compounds. (This 
will be commented upon later when considering 
structural / 
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structural differences between the methylene 
and the ethylene derivatives). 
(b) The Effect of Chain Length 
(i) Tertiary Compounds. On the rat 
increasing the chain length from 
methylene to ethylene does not affect 
activity except in the 0C- isomers in 
which activity is increased. On the 
chick the of pyridyl ethyl 
dialkylamines are more active than 
the of pyridyl methyl dialkylamines. 
With the ß and derivatives the 
methylene and ethylene linked 
dimethylamino compounds are similar 
in activity, ¡3 pyridyl ethyl - 
pyrrolídine and piperidine are less 
active than )3 pyridyl methyl 
pyrrolidine and piperidine, and 
pyridyl ethylpyrrolidine and 
piperidine are inactive. On the cat 
the 04 pyridyl ethyl dialkylamines 
were similar in activity to the 
o¿ pyridyl methyldialkylamines. 
/3 and ó pyridyl ethyldimethylamines 
were similar in activity to the /3 
and / 
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and 2( pyridyl methyl dimethylamines 
on the cat, but increasing the chain 
length from methylene to ethylene 
causes a big decrease in activity in 
the /3 pyrrolidino andpiperidino 
compounds and a smaller decrease in 
activity in the ) pyrrolidino and 
piperidino compounds. 
(ii) Quaternary Compounds. The-pyridyl 
methyl and ethyl trimethylammonium 
compounds were similar in activity 
in all three preparations. Increasing' 
the chain length from methylene to 
ethylene however increased the 
activity of the /3 pyridyl 
trimethylammonium compounds. The 
compounds have not been made. 
(c) The Effect of Quaternisation - In the 
quaternary compounds (such as have been studied) 
methylation reduces activity in the /3 pyridyl 
methyl piperidino compound (especially on the 
chick and cat) and to a lesser extent in the 
pyridyl methyl pyrrolidino analogue 
(activity in the cat decreased, in the chick 
unaltered and in the rat increased). Results 





























































































































































































































































































































































































































cos - c H
































Table 18) showing an increase in activity 
compared with nicotine on the rat and a decrease 
in activity on both the cat and the chick. 
In the dimethylamino compounds, however, 
activity is greatly increased. Rather 
surprisingly the isomer ( -pyridyl methyl 
trimethylammonium bromide hydrobromide) is 
equiactive with the 23 isomer on the chick, 
more active than the /3 isomer on the rat, but 
less active on the cat. It is unfortunate 
that g -pyridyl ethyl trimethylammonium has not 
been prepared. 
(d) Activity Differences in different Tests - 
Although the results in the chick and the cat are 
not dissimilar the results in the rat are often 
rather different. This is indicated in 
Table2l in which the compounds are numbered in 
order of activity. The activity of some 
compounds (marked B) is greater on the cat and 
the chick than on the rat; whereas the activity 
of others (marked S) is greater on the rat than 
on the cat. 
The compounds marked B are all /3 -pyridyl 
derivatives whereas those marked S are a mixed 
collection containing either g linkages or a 
piperidyl / 
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piperidyl group. (These compounds could also 
have been selected from Tables 17 and 18 where the 
equipotent molar ratios are given, but it is 
easier to select them when the numbers in the 
table are limited to 1 - 31). 
The high activity of certain compounds on 
the diaphragm (particularly ó compounds) could 
be explained by supposing that these acted in a 
curare -like fashion: with ii -pyridyl ethyl 
pyrrolidine and y -pyridyl ethyl piperidine 
dihydrobromides this may well be so because 
these compounds have virtually no effect on the 
chick biventer. With the quaternary compound 
' 
-pyridyl methyl trimethylammonium bromide 
hydrobromide, however, this seems unlikely as it 
does cause contracture of the chick muscle. 
The possible interference with the release of 
transmitter should also be considered. These 
points ought to be studied properly. It seems 
fairly certain at least that anticholinesterase 
properties do not seriously upset structure 
activity relationships because the relative 
activities of O( pyridyl methyl pyrrolidine and 
piperidine and o¿ pyridyl ethyl pyrrolidine and 
piperidine are not greatly different on the 
three preparations used. It may be, of course, 
that / 
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that these would be more active on the rat but 
for their anticholinesterase effects. 
Points to be explained 
The results, therefore, seem to present the 
following main problems (i) Thy are the 
y -pyridyl compounds (especially ó pyridyl 
methyl trimethylammonium bromide hydrobromide) 
so active on the rat, (ii) why does lengthening 
the chain by -CH2 - increase the activity in the 
Ox.- pyridyl alkyl derivatives of pyrrolidine 
and piperidine and (iii) why does lengthening the 
chain increase the activity of the ' -pyridyl 
derivatives of dimethylamine especially of the 
quaternary salt? It may be possible to obtain 
the answers to these questions by considering 
the structures of the ions concerned. 
III Spacial Considerations 
There is a considerable difference between 
the shapes of the methylene and ethylene com- 
pounds. In the former the basic group is held 
at an angle to the pyridine ring. In the 
tertiary cation there is rotation about the C -C 
and the C -N bonds but this is restricted to 






The most likely configuration of the 
piperidine compound is that with the ring 
inclined at an angle of 45° to the plane of the 
pyridine ring (see Figure LE) whereas the 
pyrrolidine ring is inclined at 15° 48'. The 
piperidine ring can rotate about the C -N bond 
until it is approximately at right angles to the 
pyridine'ring but the pyrrolidine ring cannot. 
This is also true for the quaternary methyl 
compounds. 
The fact that the pyrrolidyl compounds 
are active even though they are only slightly 
buckled suggests that it is unlikely that the 
bent form of the piperidyl compound is important. 
This idea is confirmed by the activity of the 
ethylene compounds where the bulk of the basic 
group can be more or less in the same plane as 
the pyridine ring (i.e. parallel to it - see 
Figure 5 ) . 
Importance of Side Chain Nitrogen Atom - The 
fact that the activities of the compounds of the 
pyrrolidyl and piperidyl series are more or less 
the same even although the arrangements of the 
groups are different suggests that it is not the 
position of the bulk of the ring which is 




Effect of Quaternisation of the Side Chain 
Nitrogen - It appears, however, that the effect 
of quaternisation may be a steric one, for it is 
different in the three series, dimethylamino, 
pyrrolidino, and piperidino. There seems to be 
a definite limit to the bulk of the groups 
which may be attached to the nitrogen without 
losing activity, even on the rat diaphragm 
(eg ß -pyridyl methyl methylpiperidinium bromide 
hydrobromide). This receives further support 
from the decrease in activity of j3 pyridyl 
methyl trimethylaannonium on successively 
replacing the onium methyl groups by ethyl groups. 
Importance of Pyridine Ring - The pyridine ring 
is obviously important because the analagous 
phenyl compounds are definitely less active. 
The differences between the pyridine ring and the 
benzene ring are few. The rings are almost 
identical in size but the electron distribution 
in the pyridine ring is not uniform: the 
nitrogen atom carries a partial negative charge 
and the 2, 4 and 6 carbon atoms have a partial 
positive charge. From the activity of the 
choline phenyl ethers it seems unlikely that it 
is the negative charge on the nitrogen which is 
important. This leaves the partial positive 
charges in the 2, 4 and 6 positions to account 
for the activity of the compounds. 
Although / 
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Although la° till now the charp,eo c 
2 and 4 position have been considere 
serious consideration must be given to the 
possibility that it is the charge on the 6 
carbon atom which is impo2tant. The effect of 
the position of the on 
of the nyridylmethyl di-lkylamines could be 
the same whether it is the 6 positio* or the 2 
or 4 position 11.4 ich is impoTnt. It would, 
however, have been expect eircumstwes 
that Vde differtnes activities of 
the a-I )3 and 71. uld not be so 
great as if it were the 2 4 carbon stoma in 
:f_ng ich were imln1-7 . is actuall 
is found in the rat kti.:7Ar -11:;n4 
compared to the other two iiratisms, the 
aetivtty :f the 441)6 
great:7 different. This 
hi 
0, t isomers is mat 
also explaim the 
of the loyrita oonoem4s am 
the ra.t the g -27rtay1 alettra 
Ow+ derirstiwe, 
rat it the 
40 are as aertiwe as 
/3 net eme szt.,, rhe dilat=Jr. -7-1-7e.tvimem 




4410; the 6 =rim= atom /1r1 
boat the serve.. 5ff,, v 
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the rat the receptor groups were clo er s hat 
the 2 or 4 carbon atoms 7R2.e. important it wOu16 
be expected that the )5 compOunaa wOUld 
be much more active than the correen,,rIng 
0( ethylene comnounds as .t?. two oositive 
cer..tres in same relative position whereas 1z the 
O ethylene compounds there is only one 
ositt7e centre. The ); methylene compounds, 
be attached in either of two 
::s wh F;as the 40C et772ene cuppounds 
.a7.ached in 
C.41 th., c.7- and the 1:;,.:.,.loJaps 
fact, the et _.-:7z1.,ene -r_cos 
acti e them,. ones, 
21bi s combined ith the =eh eater activity 
wridyl dialitylamlnea relative 
to the Cot and isomers ((see 'Table 11_9)) allazseata 
r the points of attacalmezt of tlbe 
receotor surface are =eh closer ttan in the rat 
Conselpently :,1,a;lit in taw 
eat Chick my coo= at the aite ib 
and the 2 or 4 cart= atom ratber titian tale 
carbon atom. 
There la no reason to eigIP 
distances letweez the Iolarta of 
the receptor axe emaetA7 ,,v1i-640 fit taw 
ggliPolft arrEao 2160 imate the g=atrzr astiwD_ty 
of /43 -507-111414711- etarlit- tatmealtranwriiai 
--pgrialls91- TortiVa tatinetlirOaramalituni Ti 
-b&(pRza-vt 
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because the points of attachment on the 
receptor are slightly further apart than the 
distance between the onium group and the 2 or 4 
carbon atoms in /9 pyridyl metnyl trimethyl- 
ammonium;but another i1i ay be that the 
explanation is conne-Jta': gre ter 
flexibility of the ethyLehe cund. In 
particular the position of the cnium group in the 
methyl compound is fixed fairly rigidly rhereas 
in the ethylene compound the extra lir,-,for 
examlole, allows the to a 
position either at right an-I: tek in the 
same plane as the 
In conclusion thi di prodaces the 
seculation thet in the rat diaghragm the 
molecule is et the cationic head and 
7:: a re.gati7e 7.ahtre ahona, y .A a 
r--::earh-11,21;,7 to the 6 carton pcitioy of the 
idie ring) ereas in chick and the cat 
receptor are only )24 PA an( ((correxpcmaloag, 
to the 2 or 4 position of the Imlytime 
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N The Relevance of this Discussion to 
the activity of related Compounds 
The relevance of this discussion to the 
activity of m- hydroxy trimethylammonium 
(Randall 1950), leptodactyline (Glasser 1960) 
and choline phenyl ether (Hey 1952) may be 
considered. 
It is unfortunate that no direct comparison 
has been obtained for the compounds studied here 
and m- hydroxy trimethylammonium and lepto- 
dactyline. In these compounds a partial 
positive charge is located on the ether oxygen 
atom and the oxygen -onium distance is 
approximately 5.5 °A in m- hydroxytrimethyl - 
ammonium and 7 °A in leptodactyline. 
Leptodactyline appears to be particularly active 
(8 times as active as nicotine on cat 
nictitating membrane preparation - Erspamer and 
Glasser 1960). How far this is due to the 
different size of the partial positive charges 
relative to 13 pyridyl ethyl trimethylammonium 
and how far to the different distance between 
the partial charge and the onium group it is 
impossible to say although an indication may be 
given by a study of analogues of leptodactyline 
(Erspamer - as yet unpublished). 
With / 
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With choline phenyl ether the oxygen-onium 
distance is approximately 40A. On the gan4ion 
this substance was fonnd to be 6 times ae active 
as homocholine phenyl ether in which the 
onium distance is a7tirut 5°A. If this speculalon 
is correct the deriye should be 
more active on th (assuming *If course 
that the acting i the sane 4 
way'¡. 
7e-2y resOlt obtained in 
t'nis tL cc-.7,,Tz,:.tf-ve absence of 
an7:-LLnztersse activit in the vateffnary 
delties ce 
which is maii,:ed in the ozzgen-ecatainin5 
c,_;21;;;. ,es: 26-47droxy tenZ1 twtmethgt- 
amnonium 
1). 
Xi of 41.26 z 16-7 ralvemuilp ail 
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